query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
LOKIASV2_0429_ESMFold_hypothetical_protein	4v4c-assembly3.cif.gz_F	LOKIASV2_0429_ESMFold_hypothetical_protein	4v4c-assembly3.cif.gz_F Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici	0.168	89	60	464	552	193	265	9.158E-04	139
LOKIASV2_0429_ESMFold_hypothetical_protein	2x9x-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	2x9x-assembly1.cif.gz_A STRUCTURE OF THE PILUS BACKBONE (RRGB) FROM STREPTOCOCCUS PNEUMONIAE	0.075	451	373	99	549	2	405	1.058E-05	73
LOKIASV2_0429_ESMFold_hypothetical_protein	3rpk-assembly2.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3rpk-assembly2.cif.gz_B Structure of the Full-Length Major Pilin RrgB from Streptococcus pneumoniae	0.076	461	383	89	549	146	560	5.215E-06	71
LOKIASV2_0429_ESMFold_hypothetical_protein	3irz-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	3irz-assembly1.cif.gz_A Crystal structure of functional region of UafA from Staphylococcus saprophyticus in P212121 form	0.087	465	349	96	560	10	392	3.316E-05	69
LOKIASV2_0429_ESMFold_hypothetical_protein	2y1v-assembly3.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	2y1v-assembly3.cif.gz_C Full length structure of RrgB Pilus protein from Streptococcus pneumoniae	0.073	450	376	99	548	160	566	8.059E-06	67
LOKIASV2_0429_ESMFold_hypothetical_protein	2x9y-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	2x9y-assembly1.cif.gz_A STRUCTURE OF THE PILUS BACKBONE (RRGB) FROM STREPTOCOCCUS PNEUMONIAE	0.081	451	376	99	549	2	411	3.140E-05	66
LOKIASV2_0429_ESMFold_hypothetical_protein	3kpt-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	3kpt-assembly1.cif.gz_A Crystal structure of BcpA, the major pilin subunit of Bacillus cereus	0.077	424	208	138	561	124	349	1.494E-03	65
LOKIASV2_0429_ESMFold_hypothetical_protein	3irp-assembly1.cif.gz_X	LOKIASV2_0429_ESMFold_hypothetical_protein	3irp-assembly1.cif.gz_X Crystal structure of functional region of UafA from Staphylococcus saprophyticus at 1.50 angstrom resolution	0.078	444	334	96	539	11	373	2.667E-05	65
LOKIASV2_0429_ESMFold_hypothetical_protein	3rkp-assembly2.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3rkp-assembly2.cif.gz_B Crystal structure of BcpA*(D312A), the major pilin subunit of Bacillus cereus	0.075	415	200	138	552	124	340	1.202E-03	62
LOKIASV2_0429_ESMFold_hypothetical_protein	2ww8-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	2ww8-assembly1.cif.gz_A Structure of the pilus adhesin (RrgA) from Streptococcus pneumoniae	0.129	90	70	469	549	691	780	5.620E-01	54
LOKIASV2_0429_ESMFold_hypothetical_protein	4z7i-assembly2.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	4z7i-assembly2.cif.gz_B Crystal structure of insulin regulated aminopeptidase in complex with ligand	0.115	203	154	133	335	28	202	8.998E-03	52
LOKIASV2_0429_ESMFold_hypothetical_protein	6oiu-assembly2.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	6oiu-assembly2.cif.gz_B X-ray crystal structure of the ectodomain of the Toxoplasma gondii ME49 Aminopeptidase N (TGME49_224350)	0.085	207	140	129	282	23	229	3.702E-02	52
LOKIASV2_0429_ESMFold_hypothetical_protein	6oiu-assembly3.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	6oiu-assembly3.cif.gz_C X-ray crystal structure of the ectodomain of the Toxoplasma gondii ME49 Aminopeptidase N (TGME49_224350)	0.102	207	169	129	335	23	211	2.820E-02	49
LOKIASV2_0429_ESMFold_hypothetical_protein	4wz9-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	4wz9-assembly1.cif.gz_B APN1 from Anopheles gambiae	0.106	200	161	136	335	32	212	4.358E-02	43
LOKIASV2_0429_ESMFold_hypothetical_protein	5mj6-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	5mj6-assembly1.cif.gz_A Ligand-induced conformational change of Insulin-regulated aminopeptidase: insights on catalytic mechanism and active site plasticity.	0.114	201	155	136	336	33	208	6.378E-02	42
LOKIASV2_0429_ESMFold_hypothetical_protein	4nn7-assembly1.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	4nn7-assembly1.cif.gz_C Cytokine receptor complex - Crystal form 2	0.111	80	65	470	549	2	75	5.620E-01	40
LOKIASV2_0429_ESMFold_hypothetical_protein	4hss-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	4hss-assembly1.cif.gz_A Structure of the Full-Length Major Pilin SpaD from Corynebacterium diphtheriae	0.069	424	226	129	552	142	385	4.602E-02	37
LOKIASV2_0429_ESMFold_hypothetical_protein	4hsq-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	4hsq-assembly1.cif.gz_A Crystal Structure of Domains D2 and D3 of the Major Pilin SpaD from Corynebacterium diphtheriae	0.071	415	211	138	552	16	243	1.793E-01	35
LOKIASV2_0429_ESMFold_hypothetical_protein	2zuu-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	2zuu-assembly1.cif.gz_B Crystal structure of Galacto-N-biose/Lacto-N-biose I phosphorylase in complex with GlcNAc	0.189	88	62	252	339	63	140	9.683E-01	35
LOKIASV2_0429_ESMFold_hypothetical_protein	3wfz-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	3wfz-assembly2.cif.gz_C Crystal structure of Galacto-N-Biose/Lacto-N-Biose I Phosphorylase C236Y Mutant	0.178	105	67	235	339	63	145	1.080E+00	32
LOKIASV2_0429_ESMFold_hypothetical_protein	2zuw-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	2zuw-assembly2.cif.gz_C Crystal structure of Galacto-N-biose/Lacto-N-biose I phosphorylase in complex with GlcNAc and sulfate	0.151	105	70	235	339	67	149	1.342E+00	31
LOKIASV2_0429_ESMFold_hypothetical_protein	4dwh-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	4dwh-assembly1.cif.gz_A Structure of the major type 1 pilus subunit FIMA bound to the FIMC (2.5 A resolution)	0.093	306	177	243	548	1	196	4.282E-01	30
LOKIASV2_0429_ESMFold_hypothetical_protein	6fwv-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6fwv-assembly1.cif.gz_A The Bacillus anthracis TIE protein	0.065	463	194	90	552	125	332	8.840E-02	30
LOKIASV2_0429_ESMFold_hypothetical_protein	4hss-assembly2.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	4hss-assembly2.cif.gz_B Structure of the Full-Length Major Pilin SpaD from Corynebacterium diphtheriae	0.065	415	209	138	552	144	368	4.055E-01	29
LOKIASV2_0429_ESMFold_hypothetical_protein	2zus-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	2zus-assembly1.cif.gz_B Crystal structure of Galacto-N-biose/Lacto-N-biose I phosphorylase	0.168	106	70	234	339	64	148	1.668E+00	29
LOKIASV2_0429_ESMFold_hypothetical_protein	2zus-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	2zus-assembly1.cif.gz_A Crystal structure of Galacto-N-biose/Lacto-N-biose I phosphorylase	0.128	105	70	235	339	74	154	2.578E+00	27
LOKIASV2_0429_ESMFold_hypothetical_protein	7uij-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7uij-assembly1.cif.gz_H Structural studies of B5-OspC complex	0.092	228	186	129	356	4	209	1.793E-01	25
LOKIASV2_0429_ESMFold_hypothetical_protein	7juk-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7juk-assembly1.cif.gz_A Crystal structure of PTEN with a tetra-phosphorylated tail (4p-crPTEN-13sp-T2, SDTTDSDPENEG)	0.104	80	67	468	547	189	264	2.578E+00	22
LOKIASV2_0429_ESMFold_hypothetical_protein	5vzr-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	5vzr-assembly2.cif.gz_A Crystal Structure of MERS-CoV neutralizing antibody G4 Fab	0.086	228	189	129	356	4	211	5.620E-01	21
LOKIASV2_0429_ESMFold_hypothetical_protein	1kem-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1kem-assembly1.cif.gz_H CATALYTIC ANTIBODY 28B4 FAB FRAGMENT	0.077	228	192	129	356	4	212	4.774E-01	21
LOKIASV2_0429_ESMFold_hypothetical_protein	1uyw-assembly2.cif.gz_M	LOKIASV2_0429_ESMFold_hypothetical_protein	1uyw-assembly2.cif.gz_M Crystal Structure of the antiflavivirus Fab4g2	0.103	221	175	136	356	16	211	1.204E+00	21
LOKIASV2_0429_ESMFold_hypothetical_protein	7dfp-assembly1.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	7dfp-assembly1.cif.gz_C Human dopamine D2 receptor in complex with spiperone	0.096	224	178	133	356	16	213	1.022E+00	21
LOKIASV2_0429_ESMFold_hypothetical_protein	5yfi-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5yfi-assembly1.cif.gz_H Crystal structure of the anti-human prostaglandin E receptor EP4 antibody Fab fragment	0.092	221	177	136	356	17	212	2.771E-01	21
LOKIASV2_0429_ESMFold_hypothetical_protein	6qex-assembly1.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	6qex-assembly1.cif.gz_C Nanodisc reconstituted human ABCB1 in complex with UIC2 fab and taxol	0.098	224	179	133	356	16	215	5.620E-01	20
LOKIASV2_0429_ESMFold_hypothetical_protein	4tuo-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	4tuo-assembly2.cif.gz_C Crystal structure of monoclonal antibody against neuroblastoma associated antigen.	0.083	229	186	129	357	2	205	1.204E+00	19
LOKIASV2_0429_ESMFold_hypothetical_protein	1jnn-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1jnn-assembly1.cif.gz_H Crystal Structure of Fab-Estradiol Complexes	0.085	230	188	129	358	4	209	1.140E+00	19
LOKIASV2_0429_ESMFold_hypothetical_protein	7txw-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7txw-assembly1.cif.gz_H Crystal structure of the complex of the malaria sexual stage protein and vaccine target Pfs25 with the Fab fragment of a transmission blocking antibody 1G2	0.071	228	190	129	356	4	209	1.342E+00	19
LOKIASV2_0429_ESMFold_hypothetical_protein	7mwx-assembly2.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	7mwx-assembly2.cif.gz_E Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2 with tamarin CD81	0.089	222	178	136	357	17	212	1.762E+00	19
LOKIASV2_0429_ESMFold_hypothetical_protein	1q72-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1q72-assembly1.cif.gz_H Anti-Cocaine Antibody M82G2 Complexed with Cocaine	0.106	228	187	129	356	4	213	1.496E+00	19
LOKIASV2_0429_ESMFold_hypothetical_protein	3t4y-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3t4y-assembly1.cif.gz_B S25-2- KDO monosaccharide complex	0.086	221	181	136	356	17	215	1.022E+00	19
LOKIASV2_0429_ESMFold_hypothetical_protein	1h0d-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	1h0d-assembly1.cif.gz_B Crystal structure of Human Angiogenin in complex with Fab fragment of its monoclonal antibody mAb 26-2F	0.094	228	190	129	356	4	214	8.225E-01	19
LOKIASV2_0429_ESMFold_hypothetical_protein	4ki5-assembly1.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	4ki5-assembly1.cif.gz_E Cystal structure of human factor VIII C2 domain in a ternary complex with murine inhbitory antibodies 3E6 and G99	0.091	228	192	129	356	4	215	7.790E-01	19
LOKIASV2_0429_ESMFold_hypothetical_protein	3dgg-assembly3.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3dgg-assembly3.cif.gz_B Crystal structure of FabOX108	0.080	228	185	129	356	4	205	9.171E-01	18
LOKIASV2_0429_ESMFold_hypothetical_protein	5w0k-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5w0k-assembly1.cif.gz_H Crystal structure of EBV gHgL/CL40/gp42 N-domain	0.087	219	172	138	356	17	205	1.964E+00	18
LOKIASV2_0429_ESMFold_hypothetical_protein	2w9e-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2w9e-assembly1.cif.gz_H Structure of ICSM 18 (anti-Prp therapeutic antibody) Fab fragment complexed with human Prp fragment 119-231	0.089	228	186	129	356	4	208	1.204E+00	18
LOKIASV2_0429_ESMFold_hypothetical_protein	2jel-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2jel-assembly1.cif.gz_H JEL42 FAB/HPR COMPLEX	0.078	228	191	129	356	4	211	1.668E+00	18
LOKIASV2_0429_ESMFold_hypothetical_protein	7t0k-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7t0k-assembly1.cif.gz_H Crystal structure of S25-2 Fab Unliganded 4	0.089	228	189	129	356	4	211	1.342E+00	18
LOKIASV2_0429_ESMFold_hypothetical_protein	7c6a-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7c6a-assembly1.cif.gz_H Crystal structure of AT2R-BRIL and SRP2070_Fab complex	0.088	225	181	132	356	13	212	1.496E+00	18
LOKIASV2_0429_ESMFold_hypothetical_protein	7wlw-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7wlw-assembly1.cif.gz_H X-ray structure of thermostabilized Drosophila dopamine transporter with GABA transporter1-like substitutions in the binding site, in complex with SKF89976a	0.083	221	179	136	356	17	212	1.860E+00	18
LOKIASV2_0429_ESMFold_hypothetical_protein	3gk8-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3gk8-assembly1.cif.gz_H X-ray crystal structure of the Fab from MAb 14, mouse antibody against Canine Parvovirus	0.084	225	180	133	357	16	213	1.668E+00	18
LOKIASV2_0429_ESMFold_hypothetical_protein	1mpa-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1mpa-assembly1.cif.gz_H BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS	0.077	228	194	129	356	4	214	1.417E+00	18
LOKIASV2_0429_ESMFold_hypothetical_protein	4wcy-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4wcy-assembly1.cif.gz_H Fab fragment of mouse AZ130 monoclonal antibody	0.088	228	182	129	356	3	203	1.496E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	6z7z-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	6z7z-assembly1.cif.gz_B Porcine insulin in complex with the analytical antibody OXI-005 Fab	0.096	221	169	136	356	17	204	1.668E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	3cfc-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3cfc-assembly1.cif.gz_H High-resolution structure of blue fluorescent antibody EP2-19G2	0.080	226	185	131	356	6	207	2.578E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	6pdr-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6pdr-assembly1.cif.gz_H Vaccine-elicited murine FP-targeting antibody vFP25.18 in complex with HIV fusion peptide (residue 512-519)	0.098	228	182	129	356	4	206	1.580E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	1yqv-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1yqv-assembly1.cif.gz_H The crystal structure of the antibody Fab HyHEL5 complex with lysozyme at 1.7A resolution	0.074	229	191	129	357	4	210	1.417E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	1mam-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1mam-assembly1.cif.gz_H CRYSTAL STRUCTURE TO 2.45 A RESOLUTION OF A MONOCLONAL FAB SPECIFIC FOR THE BRUCELLA A CELL WALL POLYSACCHARIDE ANTIGEN	0.076	228	191	129	356	4	211	1.417E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	1t4k-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	1t4k-assembly1.cif.gz_B Crystal Structure of Unliganded Aldolase Antibody 93F3 Fab	0.081	228	189	129	356	4	210	1.140E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	6ohg-assembly1.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	6ohg-assembly1.cif.gz_C Structure of Plasmodium falciparum vaccine candidate Pfs230D1M in complex with the Fab of a transmission blocking antibody	0.103	219	175	138	356	17	212	9.683E-01	17
LOKIASV2_0429_ESMFold_hypothetical_protein	7oo2-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	7oo2-assembly2.cif.gz_C Crystal structure of an antibody targeting the capsular polysaccharide of serogroup X Neisseria meningitidis (MenX)	0.097	228	184	129	356	4	208	1.342E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	5vzr-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5vzr-assembly1.cif.gz_H Crystal Structure of MERS-CoV neutralizing antibody G4 Fab	0.095	228	186	129	356	4	210	4.282E-01	17
LOKIASV2_0429_ESMFold_hypothetical_protein	1qkz-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1qkz-assembly1.cif.gz_H Fab fragment (MN14C11.6) in complex with a peptide antigen derived from Neisseria meningitidis P1.7 serosubtype antigen and domain II from Streptococcal protein G	0.106	221	174	136	356	17	212	2.074E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	6pxh-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6pxh-assembly2.cif.gz_H Crystal Structure of MERS-CoV S1-NTD bound with G2 Fab	0.076	228	191	129	356	4	211	2.074E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	6u1t-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6u1t-assembly1.cif.gz_H Crystal structure of anti-Nipah virus (NiV) F 5B3 antibody Fab fragment	0.081	226	188	131	356	6	211	1.580E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	2dqu-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2dqu-assembly1.cif.gz_H Crystal form II: high resolution crystal structure of the complex of the hydrolytic antibody Fab 6D9 and a transition-state analog	0.098	221	177	136	356	17	213	1.022E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	7c94-assembly2.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	7c94-assembly2.cif.gz_E Crystal structure of the anti-human podoplanin antibody Fab fragment complex with glycopeptide	0.088	229	192	129	357	4	214	1.964E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	6a0x-assembly3.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	6a0x-assembly3.cif.gz_E Crystal structure of broadly neutralizing antibody 13D4	0.097	224	181	133	356	16	216	1.860E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	3bkm-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3bkm-assembly1.cif.gz_H Structure of anti-amyloid-beta Fab WO2 (Form A, P212121)	0.089	221	183	136	356	16	217	1.860E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	7fci-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7fci-assembly1.cif.gz_H human NTCP in complex with YN69083 Fab	0.076	224	184	133	356	16	215	2.578E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	6sjl-assembly1.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	6sjl-assembly1.cif.gz_C Structure of the Tle1 effector bound to the VgrG spike from the Type 6 secretion system	0.151	179	149	372	548	142	320	3.573E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	1v3l-assembly2.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	1v3l-assembly2.cif.gz_B Crystal structure of F283L mutant cyclodextrin glycosyltransferase complexed with a pseudo-tetraose derived from acarbose	0.061	421	245	132	552	416	677	1.496E+00	17
LOKIASV2_0429_ESMFold_hypothetical_protein	5mu0-assembly8.cif.gz_O	LOKIASV2_0429_ESMFold_hypothetical_protein	5mu0-assembly8.cif.gz_O ACC1 Fab fragment in complex with citrullinated C1 epitope of CII (IA03)	0.097	228	182	129	356	3	205	3.384E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	7k7r-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	7k7r-assembly1.cif.gz_B EBNA1 peptide AA386-405 with Fab MS39p2w174	0.083	228	185	131	358	5	207	9.683E-01	16
LOKIASV2_0429_ESMFold_hypothetical_protein	6bpc-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	6bpc-assembly1.cif.gz_B Plasmodium vivax reticulocyte binding protein 2b (PvRBP2b) bound to monoclonal antibody 4F7	0.086	224	174	133	356	16	206	2.190E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	7tcq-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7tcq-assembly2.cif.gz_A Crystal structure of SARS-CoV-2 neutralizing antibody WS6 in complex with spike S2 peptide	0.088	219	172	138	356	17	206	2.190E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	6aq7-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6aq7-assembly1.cif.gz_H Structure of POM6 FAB fragment complexed with mouse PrPc	0.053	228	193	129	356	3	207	1.140E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	1jnh-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	1jnh-assembly1.cif.gz_B Crystal Structure of Fab-Estradiol Complexes	0.093	219	173	138	356	17	208	1.580E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	4okv-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	4okv-assembly1.cif.gz_A Crystal structure of anopheline anti-platelet protein with Fab antibody	0.085	222	174	136	357	17	207	1.580E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	4zpt-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4zpt-assembly2.cif.gz_H Structure of MERS-Coronavirus Spike Receptor-binding Domain (England1 Strain) in Complex with Vaccine-Elicited Murine Neutralizing Antibody D12 (Crystal Form 1)	0.093	221	172	136	356	17	207	2.074E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	1bm3-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1bm3-assembly1.cif.gz_H IMMUNOGLOBULIN OPG2 FAB-PEPTIDE COMPLEX	0.075	228	188	129	356	4	207	1.964E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	5od0-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5od0-assembly1.cif.gz_H Crystal structure of ACPA E4	0.117	209	159	136	344	17	197	2.442E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	5l88-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5l88-assembly1.cif.gz_H AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1- GLYCOSILATED, CRYSTAL FORM I, non-parsimonious model	0.076	229	190	129	357	4	210	2.578E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	6lkt-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6lkt-assembly1.cif.gz_A Crystal structure of the Fab fragment of murine monoclonal antibody KH-1 against Human herpesvirus 6B	0.085	224	178	133	356	16	211	1.860E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	4u6h-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	4u6h-assembly1.cif.gz_A Vaccinia L1/M12B9-Fab complex	0.089	228	188	129	356	4	210	2.074E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	4uom-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4uom-assembly1.cif.gz_H Electron Cryo-microscopy of Venezuelan Equine Encephalitis Virus TC- 83 in complex with neutralizing antibody Fab F5	0.094	228	186	129	356	4	209	1.964E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	1cf8-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1cf8-assembly1.cif.gz_H Convergence of catalytic antibody and terpene cyclase mechanisms: polyene cyclization directed by carbocation-pi interactions	0.088	228	187	129	356	4	209	1.964E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	8j7w-assembly1.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	8j7w-assembly1.cif.gz_E Cryo-EM structure of hZnT7-Fab complex in zinc state 2, determined in heterogeneous conformations- one subunit in an inward-facing zinc-bound and the other in an outward-facing zinc-bound conformation	0.081	223	180	136	358	17	213	2.074E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	5ocx-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5ocx-assembly1.cif.gz_H Crystal structure of ACPA E4 in complex with CII-C-13-CIT	0.112	221	172	136	356	17	211	1.860E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	4i2x-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	4i2x-assembly2.cif.gz_D Crystal structure of Signal Regulatory Protein gamma (SIRP-gamma) in complex with FabOX117	0.081	228	191	129	356	4	212	2.074E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	5lqb-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5lqb-assembly1.cif.gz_H Complex structure of human IL2 mutant, Proleukin, with Fab fragment of NARA1 antibody	0.087	228	191	129	356	4	213	1.964E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	3oz9-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3oz9-assembly1.cif.gz_H Crystal Structure of anti-gp41 Fab NC-1	0.097	228	188	129	356	4	212	2.312E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	5yup-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5yup-assembly1.cif.gz_H Crystal Structure of the Fab fragment of FVIIa antibody mAb4F5	0.087	217	176	140	356	17	210	2.874E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	5az2-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5az2-assembly1.cif.gz_H Crystal structure of the Fab fragment of 9E5, a murine monoclonal antibody specific for human epiregulin	0.095	224	175	133	356	16	209	1.762E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	1l7t-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1l7t-assembly1.cif.gz_H Crystal Structure Analysis of the anti-testosterone Fab fragment	0.092	226	186	131	356	6	211	1.762E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	5b4m-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	5b4m-assembly2.cif.gz_C Crystal structure of an Fab against human influenza A	0.070	228	195	131	358	6	216	1.496E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	4tnw-assembly1.cif.gz_J	LOKIASV2_0429_ESMFold_hypothetical_protein	4tnw-assembly1.cif.gz_J C. elegans glutamate-gated chloride channel (GluCl) in complex with Fab and POPC in a lipid-modulated conformation	0.098	228	190	129	356	4	215	1.668E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	6vrq-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6vrq-assembly1.cif.gz_A Crystal structure of gl12A21 Fab in complex with anti-idiotypic iv12 Fab	0.064	229	199	129	357	4	217	1.342E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	6zec-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6zec-assembly1.cif.gz_H Crystal Structure of the Fab Fragment of a Glycosylated Lymphoma Antibody	0.106	215	190	142	356	3	216	1.271E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	6ule-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6ule-assembly1.cif.gz_A Crystal structure of 2541 Fab in complex with circumsporozoite protein NANP5	0.083	214	183	131	344	6	206	4.282E-01	16
LOKIASV2_0429_ESMFold_hypothetical_protein	5ywy-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5ywy-assembly1.cif.gz_H Crystal structure of the human prostaglandin E receptor EP4 in complex with Fab and ONO-AE3-208	0.085	221	180	136	356	17	214	1.080E+00	16
LOKIASV2_0429_ESMFold_hypothetical_protein	3hzm-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3hzm-assembly1.cif.gz_B Crystal structure of S73-2 antibody in complex with antigen Kdo	0.095	221	182	136	356	17	218	9.683E-01	16
LOKIASV2_0429_ESMFold_hypothetical_protein	5vjq-assembly4.cif.gz_G	LOKIASV2_0429_ESMFold_hypothetical_protein	5vjq-assembly4.cif.gz_G Complex between HyHEL10 Fab fragment heavy chain mutant (I29F, S52T, Y53F) and Pekin duck egg lysozyme isoform I (DEL-I)	0.102	221	164	136	356	17	200	2.190E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	2y6s-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2y6s-assembly2.cif.gz_H Structure of an Ebolavirus-protective antibody in complex with its mucin-domain linear epitope	0.073	228	181	129	356	4	199	2.190E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	4tuk-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4tuk-assembly1.cif.gz_H Crystal structure of monoclonal antibody against neuroblastoma associated antigen.	0.103	217	165	140	356	16	200	2.312E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	2xkn-assembly2.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	2xkn-assembly2.cif.gz_B Crystal structure of the Fab fragment of the anti-EGFR antibody 7A7	0.083	226	181	131	356	6	203	1.762E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	6bfq-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6bfq-assembly2.cif.gz_A The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies	0.086	217	171	140	356	16	203	1.342E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	1mex-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1mex-assembly1.cif.gz_H Antibody Catalysis of a Bimolecular Cycloaddition Reaction	0.072	228	186	129	356	4	204	2.442E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	8szy-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	8szy-assembly2.cif.gz_C Crystal Structure of Heterotrimeric Anti-TIGIT Fabs in complex with human TIGIT	0.066	228	189	129	356	3	205	1.668E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	4onf-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4onf-assembly1.cif.gz_H Fab fragment of 3D6 in complex with amyloid beta 1-7	0.074	226	184	131	356	6	205	2.722E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	6bfq-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6bfq-assembly1.cif.gz_H The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies	0.093	217	172	140	356	16	206	1.417E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	6csf-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6csf-assembly2.cif.gz_H Crystal structure of sodium/alanine symporter AgcS with D-alanine bound	0.072	228	188	129	356	4	207	2.074E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	4amk-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4amk-assembly1.cif.gz_H Fab fragment of antiporphrin antibody 13g10	0.061	219	181	138	356	15	208	2.578E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	5b3j-assembly3.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	5b3j-assembly3.cif.gz_E Activation of NMDA receptors and the mechanism of inhibition by ifenprodil	0.083	225	180	134	358	14	210	2.442E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	1mhh-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	1mhh-assembly1.cif.gz_B Structure of P. magnus protein L mutant bound to a mouse Fab	0.070	228	191	129	356	4	209	3.205E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	2dtm-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2dtm-assembly1.cif.gz_H Thermodynamic and structural analyses of hydrolytic mechanism by catalytic antibodies	0.107	221	170	136	356	17	207	2.312E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	7nx2-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	7nx2-assembly2.cif.gz_D Unbound antigen-binding fragment (FAb) 324	0.090	228	187	129	356	4	209	2.578E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	4web-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4web-assembly1.cif.gz_H Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2	0.101	225	174	133	357	16	210	2.442E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	2bdn-assembly1.cif.gz_H-2	LOKIASV2_0429_ESMFold_hypothetical_protein	2bdn-assembly1.cif.gz_H-2 Crystal structure of human MCP-1 bound to a blocking antibody, 11K2	0.098	224	175	133	356	16	210	3.384E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	6dc8-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6dc8-assembly1.cif.gz_H Fab/epitope complex of mouse monoclonal antibody 8B2 targeting a non-phosphorylated tau epitope.	0.084	228	189	129	356	4	210	2.442E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	7kyo-assembly1.cif.gz_H-2	LOKIASV2_0429_ESMFold_hypothetical_protein	7kyo-assembly1.cif.gz_H-2 PsaBC from Streptococcus pneumoniae in complex with Fab	0.075	226	187	131	356	6	208	2.190E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	3o41-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	3o41-assembly2.cif.gz_A Crystal Structure of 101F Fab Bound to 15-mer Peptide Epitope	0.085	219	177	138	356	17	210	2.312E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	2a6d-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2a6d-assembly1.cif.gz_H Crystal structure analysis of the anti-arsonate germline antibody 36-65 in complex with a phage display derived dodecapeptide RLLIADPPSPRE	0.065	228	193	129	356	4	210	1.342E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	4ebq-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4ebq-assembly1.cif.gz_H Fab structure of anti-Vaccinia virus D8L antigen mouse IgG2a LA5	0.076	228	189	129	356	4	209	1.964E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	1mlc-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	1mlc-assembly2.cif.gz_D MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME COMPLEXED WITH LYSOZYME	0.066	228	191	129	356	4	209	3.384E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	3okd-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3okd-assembly1.cif.gz_B Crystal structure of S25-39 in complex with Kdo	0.085	228	190	129	356	4	212	2.442E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	3bae-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3bae-assembly1.cif.gz_H Crystal structure of Fab WO2 bound to the N terminal domain of Amyloid beta peptide (1-28)	0.087	225	183	132	356	12	212	1.964E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	4odu-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	4odu-assembly2.cif.gz_A Unliganded Fab structure of lipid A-specific antibody S1-15	0.079	221	182	136	356	17	215	1.860E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	6s3t-assembly4.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	6s3t-assembly4.cif.gz_E P46, an immunodominant surface protein from Mycoplasma hyopneumoniae	0.096	221	177	136	356	17	213	1.964E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	3vg0-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3vg0-assembly1.cif.gz_H Antibody Fab fragment	0.088	229	189	129	357	4	211	1.668E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	4xx1-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4xx1-assembly1.cif.gz_H Low resolution structure of LCAT in complex with Fab1	0.086	214	180	131	344	5	202	6.266E-01	15
LOKIASV2_0429_ESMFold_hypothetical_protein	7a5s-assembly1.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	7a5s-assembly1.cif.gz_I Complex of SARS-CoV-2 spike and CR3022 Fab (Homogeneous Refinement)	0.088	227	182	132	358	13	213	2.874E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	2h2s-assembly1.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	2h2s-assembly1.cif.gz_E Crystal Structure of E148A mutant of CLC-ec1 in SeCN-	0.079	221	181	136	356	16	213	2.312E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	6x7w-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6x7w-assembly2.cif.gz_H Vaccine-elicited mouse FP-targeting neutralizing antibody vFP49.02 in complex with HIV fusion peptide (residue 512-519)	0.087	228	191	129	356	4	213	1.668E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	6elu-assembly4.cif.gz_K	LOKIASV2_0429_ESMFold_hypothetical_protein	6elu-assembly4.cif.gz_K Structure of Serum Resistance Associated protein from T. b. rhodesiense	0.091	228	191	129	356	4	214	2.312E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	1kn2-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1kn2-assembly1.cif.gz_H CATALYTIC ANTIBODY D2.3 COMPLEX	0.082	228	195	129	356	4	216	3.773E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	1ncw-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1ncw-assembly1.cif.gz_H Cationic Cyclization Antibody 4C6 in Complex with Benzoic Acid	0.091	225	179	133	357	16	213	2.074E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	7syz-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7syz-assembly1.cif.gz_H Hendra virus G protein head domain in complex with cross-neutralizing murine antibody hAH1.3	0.079	221	181	136	356	17	214	4.207E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	2aab-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2aab-assembly1.cif.gz_H Structural basis of antigen mimicry in a clinically relevant melanoma antigen system	0.092	221	181	136	356	17	216	1.860E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	5vga-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	5vga-assembly1.cif.gz_B Alternative model for Fab 36-65	0.074	228	194	129	356	4	214	3.384E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	6qig-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6qig-assembly1.cif.gz_H Metalloproteinase	0.084	228	196	129	356	4	218	2.074E+00	15
LOKIASV2_0429_ESMFold_hypothetical_protein	4x8j-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	4x8j-assembly2.cif.gz_A Crystal Structure of murine 12F4 Fab monoclonal antibody against ADAMTS5	0.086	228	172	129	356	4	192	3.573E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	2zkh-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2zkh-assembly1.cif.gz_H Human thrombopoietin neutralizing antibody TN1 FAB	0.091	228	180	129	356	4	202	4.207E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	1ndg-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	1ndg-assembly1.cif.gz_B Crystal structure of Fab fragment of antibody HyHEL-8 complexed with its antigen lysozyme	0.079	216	177	129	344	4	196	3.573E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	3dif-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3dif-assembly1.cif.gz_B Crystal structure of FabOX117	0.078	228	185	129	356	4	205	3.384E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	6wqo-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	6wqo-assembly1.cif.gz_B Plasmodium vivax reticulocyte binding protein 2b (PvRBP2b) bound to human monoclonal antibody 283284	0.107	224	171	133	356	14	206	1.762E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	6y54-assembly2.cif.gz_M	LOKIASV2_0429_ESMFold_hypothetical_protein	6y54-assembly2.cif.gz_M Crystal structure of a Neisseria meningitidis serogroup A capsular oligosaccharide bound to a functional Fab	0.074	217	173	140	356	17	204	2.442E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	6bit-assembly1.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	6bit-assembly1.cif.gz_I SIRPalpha antibody complex	0.106	224	170	133	356	16	206	2.074E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	3liz-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3liz-assembly1.cif.gz_H crystal structure of bla g 2 complexed with Fab 4C3	0.099	221	170	136	356	17	206	2.578E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	6wwc-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	6wwc-assembly2.cif.gz_D Vaccine-elicited mouse FP-targeting neutralizing antibody vFP16.02 with S48K mutation in light chain in complex with HIV fusion peptide (residue 512-519)	0.087	219	173	138	356	17	207	8.225E-01	14
LOKIASV2_0429_ESMFold_hypothetical_protein	3gbm-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3gbm-assembly1.cif.gz_H Crystal Structure of Fab CR6261 in Complex with a H5N1 influenza virus hemagglutinin.	0.077	224	177	133	356	16	208	1.496E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	2gsi-assembly3.cif.gz_F	LOKIASV2_0429_ESMFold_hypothetical_protein	2gsi-assembly3.cif.gz_F Crystal Structure of a Murine Fab in Complex with an 11 Residue Peptide Derived from Staphylococcal Nuclease	0.063	225	183	132	356	12	207	2.874E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	3ifl-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3ifl-assembly1.cif.gz_H X-ray structure of amyloid beta peptide:antibody (Abeta1-7:12A11) complex	0.089	219	173	138	356	17	207	2.722E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	1mhh-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	1mhh-assembly2.cif.gz_D Structure of P. magnus protein L mutant bound to a mouse Fab	0.085	228	187	129	356	4	208	3.384E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	4etq-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4etq-assembly1.cif.gz_H Vaccinia virus D8L IMV envelope protein in complex with Fab of murine IgG2a LA5	0.070	228	190	129	356	4	208	2.722E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	2gsi-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	2gsi-assembly2.cif.gz_D Crystal Structure of a Murine Fab in Complex with an 11 Residue Peptide Derived from Staphylococcal Nuclease	0.068	228	191	129	356	3	208	4.442E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	5l9d-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5l9d-assembly1.cif.gz_H AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1- GLYCOSYLATED, CRYSTAL FORM I, parsimonious model	0.073	229	189	129	357	4	208	3.773E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	6otc-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6otc-assembly2.cif.gz_H Synthetic Fab bound to Marburg virus VP35 interferon inhibitory domain	0.080	230	191	129	358	4	212	2.312E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	7qt3-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7qt3-assembly1.cif.gz_A Antibody FenAb609 - fentanyl complex	0.081	219	176	138	356	17	209	5.229E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	7tcq-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7tcq-assembly1.cif.gz_H Crystal structure of SARS-CoV-2 neutralizing antibody WS6 in complex with spike S2 peptide	0.080	228	189	129	356	4	209	3.773E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	1a4k-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1a4k-assembly1.cif.gz_H DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE	0.090	203	181	142	344	4	203	4.442E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	1eo8-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1eo8-assembly1.cif.gz_H INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY	0.075	228	191	129	356	4	211	1.668E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	5myx-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	5myx-assembly1.cif.gz_B Structure of Pyroglutamate-Abeta-specific Fab c#24 in complex with human Abeta-pE3-18	0.088	228	186	129	356	4	208	3.035E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	4nj9-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4nj9-assembly1.cif.gz_H Crystal structure of Fab 8B10 in complex with MPTS	0.073	219	178	138	356	17	209	2.722E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	3gnm-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3gnm-assembly1.cif.gz_H The crystal structure of the JAA-F11 monoclonal antibody Fab fragment	0.070	221	182	138	358	17	213	4.952E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	1xf3-assembly2.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	1xf3-assembly2.cif.gz_B Structure of ligand-free Fab DNA-1 in space group P65	0.073	224	179	133	356	16	209	3.773E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	1c1e-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1c1e-assembly1.cif.gz_H CRYSTAL STRUCTURE OF A DIELS-ALDERASE CATALYTIC ANTIBODY 1E9 IN COMPLEX WITH ITS HAPTEN	0.112	204	173	153	356	17	212	3.573E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	5epm-assembly2.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	5epm-assembly2.cif.gz_E Ceratotoxin variant in complex with specific antibody Fab fragment	0.088	224	179	133	356	16	212	3.773E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	2gfb-assembly3.cif.gz_F	LOKIASV2_0429_ESMFold_hypothetical_protein	2gfb-assembly3.cif.gz_F CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY	0.083	217	178	140	356	17	211	4.690E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	6gxx-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6gxx-assembly1.cif.gz_H Fab fragment of an antibody selective for alpha-1-antitrypsin in the native conformation	0.100	221	176	136	356	17	212	1.080E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	5h35-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	5h35-assembly1.cif.gz_A Crystal structures of the TRIC trimeric intracellular cation channel orthologue from Sulfolobus solfataricus	0.079	228	192	129	356	3	212	3.773E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	5mvj-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5mvj-assembly1.cif.gz_H Structure of DC8E8 Fab at pH 6.5 crystallized in space-group P1	0.094	228	188	129	356	4	212	2.190E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	3hzv-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3hzv-assembly1.cif.gz_B Crystal structure of S73-2 antibody in complex with antigen Kdo(2.8)Kdo(2.4)Kdo	0.097	226	187	131	356	6	213	8.685E-01	14
LOKIASV2_0429_ESMFold_hypothetical_protein	1kno-assembly3.cif.gz_F	LOKIASV2_0429_ESMFold_hypothetical_protein	1kno-assembly3.cif.gz_F CRYSTAL STRUCTURE OF THE COMPLEX OF A CATALYTIC ANTIBODY FAB WITH A TRANSITION STATE ANALOG: STRUCTURAL SIMILARITIES IN ESTERASE-LIKE ABZYMES	0.093	226	187	131	356	6	212	3.573E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	5ock-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5ock-assembly1.cif.gz_H Crystal structure of ACPA E4 in complex with CEP1	0.129	209	160	136	344	17	201	3.384E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	7dr4-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7dr4-assembly1.cif.gz_H Complex of anti-human IL-2 antibody and human IL-2	0.095	228	190	129	356	4	214	3.205E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	3hzk-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3hzk-assembly1.cif.gz_B Crystal structure of S73-2 antibody in complex with antigen Kdo(2.4)Kdo	0.121	221	174	136	356	17	215	1.417E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	3okl-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3okl-assembly1.cif.gz_B Crystal structure of S25-39 in complex with Kdo(2.8)Kdo	0.080	214	183	131	344	6	205	2.722E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	4q6i-assembly4.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4q6i-assembly4.cif.gz_H Crystal structure of murine 2D5 Fab, a potent anti-CD4 HIV-1-neutralizing antibody in complex with CD4	0.081	227	191	131	357	6	214	5.522E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	7qu1-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7qu1-assembly1.cif.gz_A Machupo virus GP1 glycoprotein in complex with Fab fragment of antibody MAC1	0.088	228	191	129	356	5	214	3.573E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	6x7w-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6x7w-assembly1.cif.gz_A Vaccine-elicited mouse FP-targeting neutralizing antibody vFP49.02 in complex with HIV fusion peptide (residue 512-519)	0.097	228	190	129	356	4	214	2.722E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	7f9w-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	7f9w-assembly1.cif.gz_B CD25 in complex with Fab	0.080	221	183	136	356	16	215	1.860E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	3w2d-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3w2d-assembly1.cif.gz_H Crystal Structure of Staphylococcal Eenterotoxin B in complex with a novel neutralization monoclonal antibody Fab fragment	0.081	228	193	129	356	4	214	1.080E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	4uim-assembly3.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	4uim-assembly3.cif.gz_E crystal structure of quinine-dependent Fab 314.3	0.098	219	179	138	356	17	215	1.964E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	3ra7-assembly2.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	3ra7-assembly2.cif.gz_I Bispecific digoxigenin binding antibodies for targeted payload delivery	0.090	228	195	129	356	4	218	2.190E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	5bzd-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	5bzd-assembly2.cif.gz_D Crystal Structure of PCDN-27A, an antibody from the PCDN family of HIV-1 antibodies	0.100	225	184	132	356	13	217	1.204E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	4z95-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4z95-assembly1.cif.gz_H Fab structure of antibody S1-15 in complex with ssDNA DNA, 5'-5(dT)-p-3'	0.086	228	197	129	356	4	220	4.207E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	8hq7-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	8hq7-assembly1.cif.gz_H Cryo-EM structure of SARS-CoV-2 Omicron Prototype RBD in complex with fab L4.65 and L5.34	0.092	216	189	129	344	4	212	2.578E+00	14
LOKIASV2_0429_ESMFold_hypothetical_protein	4tul-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4tul-assembly1.cif.gz_H Crystal structure of monoclonal antibody against neuroblastoma associated antigen.	0.076	228	181	129	356	3	199	4.952E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	4ag4-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4ag4-assembly1.cif.gz_H Crystal structure of a DDR1-Fab complex	0.083	211	180	146	356	7	203	4.690E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	8duz-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	8duz-assembly1.cif.gz_A Protective antibody against gonococcal lipooligosaccharide bound to peptide mimetic	0.088	212	162	133	344	15	193	2.442E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	2b2x-assembly2.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	2b2x-assembly2.cif.gz_I VLA1 RdeltaH I-domain complexed with a quadruple mutant of the AQC2 Fab	0.083	222	172	136	357	17	205	4.952E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	7bg1-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7bg1-assembly1.cif.gz_H Structure of anti-FLAG M2 Fab domain remodeled based on proteomic sequencing	0.101	219	167	138	356	17	203	1.580E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	7chf-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7chf-assembly1.cif.gz_H Crystal structure of the SARS-CoV-2 RBD in complex with BD-604 Fab and BD-368-2 Fab	0.073	216	176	129	344	4	194	1.204E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	6pxg-assembly4.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6pxg-assembly4.cif.gz_H Crystal Structure of MERS-CoV neutralizing antibody G2 Fab	0.086	228	183	129	356	3	203	1.204E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	5kqv-assembly1.cif.gz_C-2	LOKIASV2_0429_ESMFold_hypothetical_protein	5kqv-assembly1.cif.gz_C-2 Insulin receptor ectodomain construct comprising domains L1,CR,L2, FnIII-1 and alphaCT peptide in complex with bovine insulin and FAB 83-14 (REVISED STRUCTURE)	0.091	230	177	138	367	16	211	6.156E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	5mu2-assembly4.cif.gz_G	LOKIASV2_0429_ESMFold_hypothetical_protein	5mu2-assembly4.cif.gz_G ACC1 Fab fragment in complex with CII583-591 (CG10)	0.093	228	181	129	356	4	204	6.156E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	1a3r-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1a3r-assembly1.cif.gz_H FAB FRAGMENT (ANTIBODY 8F5) COMPLEXED WITH PEPTIDE FROM HUMAN RHINOVIRUS (SEROTYPE 2) VIRAL CAPSID PROTEIN VP2 (RESIDUES 156-170)	0.083	221	173	136	356	16	205	3.773E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	1gpo-assembly2.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	1gpo-assembly2.cif.gz_I CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT	0.107	228	180	129	356	4	206	5.830E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	5i30-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5i30-assembly1.cif.gz_H Crystal structure of the human astrovirus 2 neutralizing monoclonal antibody PL-2 Fab fragment at 1.9 A resolution	0.080	228	185	129	356	4	205	4.442E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	5mu0-assembly7.cif.gz_M	LOKIASV2_0429_ESMFold_hypothetical_protein	5mu0-assembly7.cif.gz_M ACC1 Fab fragment in complex with citrullinated C1 epitope of CII (IA03)	0.100	228	182	129	356	4	206	5.229E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	5esa-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	5esa-assembly1.cif.gz_A Crystal structure of anti-HCV E2 antibody HC84-26	0.085	228	188	129	356	4	209	8.685E-01	13
LOKIASV2_0429_ESMFold_hypothetical_protein	8gf2-assembly1.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	8gf2-assembly1.cif.gz_C Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies eCR3022.20 and CC12.3	0.070	229	189	129	357	4	207	2.190E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	4rgn-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	4rgn-assembly1.cif.gz_B Structure of Staphylococcal Enterotoxin B bound to two neutralizing antibodies, 14G8 and 6D3	0.093	220	172	138	357	17	207	1.417E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	5dlm-assembly2.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	5dlm-assembly2.cif.gz_I Complex of Influenza M2e and Antibody	0.078	228	188	129	356	3	207	4.207E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	3fzu-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	3fzu-assembly2.cif.gz_C IgG1 Fab characterized by H/D exchange	0.091	216	175	129	344	4	197	1.022E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	2hff-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	2hff-assembly1.cif.gz_B Crystal structure of CB2 Fab	0.088	228	185	129	356	4	207	2.312E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	7jvd-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7jvd-assembly1.cif.gz_H Fab of 5.6 monoclonal mouse IgG1 co-crystallized with the trisaccharide form of serotype 3 pneumococcal capsular polysaccharide	0.088	226	183	131	356	6	207	1.204E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	4k2u-assembly2.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	4k2u-assembly2.cif.gz_I Crystal structure of PfEBA-175 F1 in complex with R218 antibody Fab fragment	0.072	228	188	129	356	4	207	4.207E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	3nfp-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3nfp-assembly2.cif.gz_H Crystal structure of the Fab fragment of therapeutic antibody daclizumab in complex with IL-2Ra (CD25) ectodomain	0.076	224	177	133	356	16	208	2.578E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	3dgg-assembly3.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	3dgg-assembly3.cif.gz_D Crystal structure of FabOX108	0.073	228	188	129	356	4	207	4.442E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	6ltg-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	6ltg-assembly2.cif.gz_C Crystal structure of the Fab fragment of murine monoclonal antibody OHV-3 against Human herpesvirus 6B	0.070	229	193	129	357	2	209	5.229E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	6m87-assembly4.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6m87-assembly4.cif.gz_H Fab 10A6 in complex with MPTS	0.088	212	165	133	344	15	196	4.952E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	2ai0-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2ai0-assembly1.cif.gz_H Anti-Cocaine Antibody 7.5.21, Crystal Form III	0.069	228	190	129	356	4	208	4.442E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	6bb4-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6bb4-assembly1.cif.gz_H Fab/epitope complex of mouse monoclonal antibody C5.2 targeting a phospho-tau epitope.	0.094	228	185	129	356	4	208	4.207E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	3dsf-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3dsf-assembly1.cif.gz_H Crystal structure of anti-osteopontin antibody 23C3 in complex with W43A mutated epitope peptide	0.088	226	185	131	356	6	209	4.442E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	1hq4-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	1hq4-assembly2.cif.gz_D STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4	0.109	221	171	136	356	17	209	6.501E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	6ks2-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	6ks2-assembly1.cif.gz_B Structure of anti-Ghrelin receptor antibody	0.091	224	175	133	356	16	209	4.207E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	7u60-assembly2.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	7u60-assembly2.cif.gz_E Integrin alaphIIBbeta3 complex with cRGDfV	0.085	221	176	136	356	17	209	5.229E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	6al0-assembly1.cif.gz_H-2	LOKIASV2_0429_ESMFold_hypothetical_protein	6al0-assembly1.cif.gz_H-2 The NZ-1 Fab complexed with the PDZ tandem fragment of A. aeolicus S2P homolog with the PA12 tag inserted between the residues 263 and 267	0.086	221	176	136	356	17	210	6.864E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	1cic-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	1cic-assembly1.cif.gz_B IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225	0.072	221	179	136	356	17	210	3.984E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	3gi9-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3gi9-assembly1.cif.gz_H Crystal Structure of ApcT Transporter Bound to 7F11 Monoclonal Fab Fragment	0.070	221	180	136	356	17	211	4.207E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	7mxl-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7mxl-assembly1.cif.gz_H Complex of Bet v 1 with the Fab fragments of a three antibody cocktail	0.111	213	169	132	344	13	203	1.860E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	4rgm-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	4rgm-assembly2.cif.gz_C Structure of Staphylococcal Enterotoxin B bound to the neutralizing antibody 20B1	0.100	225	177	132	356	13	210	3.205E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	1t2q-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1t2q-assembly1.cif.gz_H The Crystal Structure of an NNA7 Fab that recognizes an N-type blood group antigen	0.062	221	178	136	356	18	208	2.874E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	5tpn-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5tpn-assembly1.cif.gz_H Crystal structure of RSV F in complex with human antibody hRSV90	0.062	221	183	136	356	16	211	1.140E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	8d36-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	8d36-assembly1.cif.gz_H Crystal structure of SARS-CoV-2 fusion peptide in complex with neutralizing antibody COV44-62	0.082	216	181	129	344	4	201	7.790E-01	13
LOKIASV2_0429_ESMFold_hypothetical_protein	4p3c-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4p3c-assembly1.cif.gz_H MT1-MMP:Fab complex (Form I)	0.081	227	189	131	357	6	212	4.442E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	6uj9-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6uj9-assembly1.cif.gz_H Crystal structure of HLA-B*07:02 with R140Q mutant IDH2 peptide in complex with Fab	0.092	216	180	129	344	4	202	4.442E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	6z7z-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	6z7z-assembly2.cif.gz_D Porcine insulin in complex with the analytical antibody OXI-005 Fab	0.111	222	172	136	357	17	211	1.964E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	3hzy-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3hzy-assembly1.cif.gz_B Crystal structure of S73-2 antibody in complex with antigen Kdo(2.4)Kdo(2.4)Kdo	0.105	221	175	136	356	17	212	1.417E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	3oko-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3oko-assembly1.cif.gz_B Crystal structure of S25-39 in complex with Kdo(2.8)Kdo(2.4)Kdo	0.093	221	177	136	356	17	212	3.773E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	4qww-assembly1.cif.gz_F	LOKIASV2_0429_ESMFold_hypothetical_protein	4qww-assembly1.cif.gz_F Crystal structure of the Fab410-BfAChE complex	0.077	228	192	129	356	4	212	1.580E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	7sbz-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7sbz-assembly1.cif.gz_A JAR5 Fab bound to fHbp v1.1 crystallized in space group I422	0.090	219	176	138	356	17	210	4.690E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	7t0j-assembly4.cif.gz_F	LOKIASV2_0429_ESMFold_hypothetical_protein	7t0j-assembly4.cif.gz_F Crystal structure of S25-2 Fab Unliganded 3	0.087	228	190	129	356	4	212	1.762E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	7tp4-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7tp4-assembly1.cif.gz_H Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K398.22	0.093	216	180	129	344	4	202	1.140E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	7u2d-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7u2d-assembly1.cif.gz_H Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADG20	0.086	214	178	131	344	6	201	1.140E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	7x8t-assembly4.cif.gz_L	LOKIASV2_0429_ESMFold_hypothetical_protein	7x8t-assembly4.cif.gz_L Frizzled 10 CRD in complex with hB9L9.3 Fab	0.083	221	180	136	356	17	213	1.080E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	1f8t-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1f8t-assembly1.cif.gz_H FAB (LNKB-2) OF MONOCLONAL ANTIBODY, CRYSTAL STRUCTURE	0.093	228	188	129	356	4	211	3.984E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	6p8n-assembly2.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	6p8n-assembly2.cif.gz_B Crystal Structure of Antibody P-p1f1 in Complex with eOD-GT8	0.091	228	190	129	356	4	213	2.442E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	12e8-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	12e8-assembly1.cif.gz_H 2E8 FAB FRAGMENT	0.091	228	190	129	356	4	213	1.964E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	4hxa-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4hxa-assembly1.cif.gz_H Crystal structure of 13D9 FAB	0.081	226	189	131	356	6	212	5.522E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	1iqw-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1iqw-assembly1.cif.gz_H CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI-HUMAN FAS ANTIBODY HFE7A	0.080	221	181	136	356	17	214	3.384E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	2r23-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	2r23-assembly1.cif.gz_B Crystal structure of S25-2 Fab in complex with Kdo analogues	0.091	228	190	129	356	4	213	1.580E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	2v17-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2v17-assembly1.cif.gz_H Structure of the complex of antibody MN423 with a fragment of tau protein	0.074	229	196	129	357	4	216	5.830E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	1yee-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1yee-assembly1.cif.gz_H STRUCTURE OF A CATALYTIC ANTIBODY, IGG2A FAB FRAGMENT (D2.5)	0.095	219	180	138	356	17	216	3.773E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	8d48-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	8d48-assembly1.cif.gz_H sd1.040 Fab in complex with SARS-CoV-2 Spike 2P glycoprotein	0.089	213	175	132	344	13	205	2.190E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	1qfu-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1qfu-assembly1.cif.gz_H INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY	0.077	205	184	153	357	17	216	1.204E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	6v4o-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6v4o-assembly1.cif.gz_A Structure of human 2E01 Fab in complex with influenza virus neuraminidase from B/Phuket/3073/2013	0.072	227	189	133	359	16	220	1.860E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	6x78-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6x78-assembly2.cif.gz_H Vaccine-elicited mouse FP-targeting neutralizing antibody vFP48.03 in complex with HIV fusion peptide (residue 512-519)	0.094	224	180	133	356	16	215	4.952E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	2brr-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2brr-assembly1.cif.gz_H Complex of the neisserial PorA P1.4 epitope peptide and two Fab- fragments (antibody MN20B9.34)	0.093	221	180	136	356	16	215	4.952E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	4qnp-assembly1.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	4qnp-assembly1.cif.gz_E Crystal structure of the 2009 pandemic H1N1 influenza virus neuraminidase with a neutralizing antibody	0.096	228	193	129	356	4	217	1.417E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	8t7f-assembly3.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	8t7f-assembly3.cif.gz_D Structure of the S1 variant of Fab F1	0.083	207	175	138	344	17	208	1.964E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	8t7f-assembly5.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	8t7f-assembly5.cif.gz_I Structure of the S1 variant of Fab F1	0.086	216	185	129	344	4	206	1.271E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	1q9o-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	1q9o-assembly1.cif.gz_B S45-18 Fab Unliganded	0.093	221	181	136	356	17	217	3.035E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	7rd5-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	7rd5-assembly2.cif.gz_D Crystal structure of Tspan15 large extracellular loop (Tspan15 LEL) in complex with 1C12 Fab	0.091	225	180	132	356	13	211	3.035E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	6usf-assembly1.cif.gz_K	LOKIASV2_0429_ESMFold_hypothetical_protein	6usf-assembly1.cif.gz_K CryoEM structure of human alpha4beta2 nicotinic acetylcholine receptor with varenicline in complex with anti-BRIL synthetic antibody BAK5	0.091	221	185	138	358	18	221	1.860E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	7qu2-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7qu2-assembly1.cif.gz_A Junin virus GP1 glycoprotein in complex with Fab fragment of antibody JUN1	0.098	221	181	136	356	20	221	4.442E+00	13
LOKIASV2_0429_ESMFold_hypothetical_protein	5vzy-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5vzy-assembly1.cif.gz_H Crystal structure of crenezumab Fab in complex with Abeta	0.084	230	180	129	358	4	201	4.442E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	7bsd-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7bsd-assembly1.cif.gz_A Complex structure of 1G5.3 Fab bound to ZIKV NS1c	0.081	228	181	129	356	4	201	1.762E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6z7y-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	6z7y-assembly2.cif.gz_D Human insulin in complex with the analytical antibody OXI-005 Fab	0.095	222	169	136	357	17	204	2.578E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	3d9a-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3d9a-assembly1.cif.gz_H High Resolution Crystal Structure Structure of HyHel10 Fab Complexed to Hen Egg Lysozyme	0.091	224	173	133	356	16	206	5.830E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	1fe8-assembly2.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	1fe8-assembly2.cif.gz_I CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING	0.091	221	168	136	356	17	202	3.984E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	4ouu-assembly2.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	4ouu-assembly2.cif.gz_B anti-MT1-MMP monoclonal antibody	0.100	226	178	131	356	6	204	1.417E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	7wph-assembly1.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	7wph-assembly1.cif.gz_E SARS-CoV2 RBD bound to Fab06	0.090	228	186	129	356	4	208	2.578E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6dc7-assembly2.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	6dc7-assembly2.cif.gz_I Apo Fab structure of mouse monoclonal antibody 8B2	0.079	228	184	129	356	4	204	4.952E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6p8d-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6p8d-assembly1.cif.gz_A Vaccine-elicited murine FP-targeting antibody vFP6.01 in complex with HIV fusion peptide (residue 512-519)	0.091	228	181	129	356	4	203	4.690E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6rlm-assembly6.cif.gz_K	LOKIASV2_0429_ESMFold_hypothetical_protein	6rlm-assembly6.cif.gz_K Crystal structure of AT1412dm Fab fragment	0.073	230	187	129	358	5	207	2.074E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6uga-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6uga-assembly1.cif.gz_H ch28/11 Fab (monoclinic form)	0.084	221	171	136	356	17	204	1.860E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	3wif-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	3wif-assembly1.cif.gz_A Crystal structure of anti-prostaglandin E2 Fab fragment 9Cl-PGF2beta complex	0.106	219	167	138	356	17	204	5.522E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6y54-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6y54-assembly1.cif.gz_H Crystal structure of a Neisseria meningitidis serogroup A capsular oligosaccharide bound to a functional Fab	0.081	217	171	140	356	17	203	4.690E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	5ye3-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	5ye3-assembly1.cif.gz_B Crystal structure of the complex of di-acetylated histone H4 and 2A7D9 Fab fragment	0.089	228	182	129	356	4	204	7.653E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	2d03-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2d03-assembly1.cif.gz_H Crystal structure of the G91S mutant of the NNA7 Fab	0.059	218	178	140	357	16	205	3.984E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	5dyo-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5dyo-assembly2.cif.gz_H Fab43.1 complex with flourescein	0.095	206	173	153	358	16	207	7.653E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	4k23-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4k23-assembly1.cif.gz_H Structure of anti-uPAR Fab ATN-658	0.090	228	183	129	356	4	205	1.417E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	5mv4-assembly8.cif.gz_U	LOKIASV2_0429_ESMFold_hypothetical_protein	5mv4-assembly8.cif.gz_U ACC1 Fab fragment in complex with citrullinated CII616-639 epitope of collagen type II (ptm23)	0.098	221	168	136	356	17	203	5.522E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6r0x-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6r0x-assembly1.cif.gz_A The extracellular domain of G6b-B in complex with Fab fragment and DP12 heparin oligosaccharide.	0.099	224	170	133	356	16	205	2.190E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	3tnn-assembly3.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	3tnn-assembly3.cif.gz_C Crystal structure of N5-i5 Fab, an ADCC mediating and non-neutralizing CD4i anti-HIV- 1 antibody.	0.085	228	185	129	356	4	206	1.762E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6uga-assembly2.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	6uga-assembly2.cif.gz_B ch28/11 Fab (monoclinic form)	0.084	230	186	129	358	4	207	1.580E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	5i9q-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5i9q-assembly2.cif.gz_H Crystal structure of 3BNC55 Fab in complex with 426c.TM4deltaV1-3 gp120	0.092	221	173	136	356	17	207	3.573E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	5mv3-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	5mv3-assembly2.cif.gz_C ACC1 Fab fragment in complex with CII583-591 (CG10)	0.115	221	165	136	356	17	204	5.522E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	3phq-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3phq-assembly1.cif.gz_B Crystal structure of S64-4 in complex with KDO	0.091	226	182	131	356	6	206	2.722E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	5d96-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	5d96-assembly2.cif.gz_C Oxidoreductase Fragment of Mouse QSOX1 in Complex with a FAb Fragment from an Antibody Targeting Mouse and Human QSOX1	0.085	228	184	129	356	4	205	5.522E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6nmt-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	6nmt-assembly1.cif.gz_B Non-Blocking Fab 3 anti-SIRP-alpha antibody in complex with SIRP-alpha Variant 1	0.072	228	188	129	356	4	207	2.578E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	5nph-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5nph-assembly1.cif.gz_H Structure of the Hepatitis C virus strain J4 glycoprotein E2 antigenic region 532-540 bound to the Fab fragment of the non-neutralizing antibody DAO5	0.076	228	188	129	356	4	207	5.830E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	7t0i-assembly2.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	7t0i-assembly2.cif.gz_B Crystal structure of S25-39 Fab Unliganded 3	0.093	228	184	129	356	4	207	4.207E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	7tho-assembly2.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	7tho-assembly2.cif.gz_E Integrin alaphIIBbeta3 complex with Eptifibatide	0.087	228	185	129	356	4	207	3.573E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6wg1-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6wg1-assembly1.cif.gz_H Crystal structure of Fab399 in complex with NPNA6 peptide from circumsporozoite protein	0.064	230	193	129	358	4	210	2.074E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	4zxb-assembly1.cif.gz_A-2	LOKIASV2_0429_ESMFold_hypothetical_protein	4zxb-assembly1.cif.gz_A-2 Structure of the human insulin receptor ectodomain, IRDeltabeta construct, in complex with four Fab molecules	0.092	221	172	136	356	17	206	1.860E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	4g7v-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4g7v-assembly1.cif.gz_H Crystal structure of voltage sensing domain of Ci-VSP with fragment antibody (R217E, 2.5 A)	0.083	216	179	129	344	4	199	1.496E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	8ivx-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	8ivx-assembly1.cif.gz_H Crystal structure of NRP2 in complex with aNRP2-14 Fab fragment	0.086	228	186	129	356	4	207	2.874E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	7qxe-assembly1.cif.gz_HHH	LOKIASV2_0429_ESMFold_hypothetical_protein	7qxe-assembly1.cif.gz_HHH Recognition of Staphylococcus aureus wall teichoic acid analogue TB87 (compound 3) by Fab4497	0.097	230	186	129	358	4	210	3.384E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	7rd3-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7rd3-assembly1.cif.gz_A Crystal structure of PfCSP peptide 21 with vaccine-elicited human anti-malaria antibody m42.126	0.089	222	177	136	357	16	210	3.035E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	4rfe-assembly4.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	4rfe-assembly4.cif.gz_E Crystal structure of ADCC-potent ANTI-HIV-1 Rhesus macaque antibody JR4 Fab	0.116	209	164	136	344	15	200	3.205E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6vrq-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6vrq-assembly1.cif.gz_H Crystal structure of gl12A21 Fab in complex with anti-idiotypic iv12 Fab	0.073	211	188	146	356	6	209	2.312E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	5c0n-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	5c0n-assembly2.cif.gz_C Development of a monoclonal antibody targeting secreted aP2 to treat diabetes and fatty liver disease	0.100	228	187	129	356	3	211	2.190E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	7fgj-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7fgj-assembly1.cif.gz_H The cross-reaction complex structure with VQILNK peptide and the tau antibody's Fab domain.	0.075	229	191	129	357	3	210	3.984E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	5mvj-assembly4.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	5mvj-assembly4.cif.gz_E Structure of DC8E8 Fab at pH 6.5 crystallized in space-group P1	0.094	224	174	133	356	16	208	2.074E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	4rgm-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4rgm-assembly1.cif.gz_H Structure of Staphylococcal Enterotoxin B bound to the neutralizing antibody 20B1	0.105	221	171	136	356	17	208	5.522E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	4s1d-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4s1d-assembly1.cif.gz_H Structure of IgG1 Fab fragment in complex with Biotincytidinamide	0.093	224	175	133	356	16	209	6.864E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	7sn1-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7sn1-assembly1.cif.gz_H Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab	0.080	226	188	131	356	6	210	1.860E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6a77-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6a77-assembly1.cif.gz_H Crystal structure of the fifth immunoglobulin domain (Ig5) of human Robo1 in complex with the Fab fragment of murine monoclonal antibody B5209B	0.094	228	188	129	356	4	211	4.442E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6bpa-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	6bpa-assembly1.cif.gz_B Plasmodium vivax reticulocyte binding protein 2b (PvRBP2b) bound to monoclonal antibody 3E9	0.098	224	173	133	356	16	208	1.964E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	1bz7-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	1bz7-assembly1.cif.gz_B FAB FRAGMENT FROM MURINE ASCITES	0.058	216	189	129	344	4	205	6.864E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	3okk-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3okk-assembly1.cif.gz_B Crystal structure of S25-39 in complex with Kdo(2.4)Kdo	0.092	226	185	131	356	6	210	2.190E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6oy4-assembly1.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	6oy4-assembly1.cif.gz_D Crystal structure of complex between recombinant Der p 2.0103 and Fab fragment of 7A1	0.101	228	185	129	356	4	210	2.722E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	7qt0-assembly1.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	7qt0-assembly1.cif.gz_E Antibody FenAb136 - fentanyl complex	0.083	221	178	136	356	17	211	1.417E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	3sge-assembly2.cif.gz_J	LOKIASV2_0429_ESMFold_hypothetical_protein	3sge-assembly2.cif.gz_J Crystal structure of mAb 17.2 in complex with R13 peptide	0.086	228	186	129	356	4	208	4.690E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	4u6h-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	4u6h-assembly2.cif.gz_C Vaccinia L1/M12B9-Fab complex	0.094	228	188	129	356	3	210	6.156E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6wgk-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	6wgk-assembly2.cif.gz_C Fab portion of dupilumab with Crystal Kappa design and intrachain disulfide	0.083	221	179	136	356	17	212	2.874E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	4xnm-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4xnm-assembly1.cif.gz_H Antibody Influenza H5 Complex	0.089	228	189	129	356	4	211	2.442E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	5bk3-assembly4.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	5bk3-assembly4.cif.gz_E Crystal structure of the neutralizing anti-circumsporozoite protein 580 antibody	0.084	221	179	136	356	17	212	1.964E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6lra-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6lra-assembly1.cif.gz_H The complex structure of PHF core domain peptide of tau and antibody's Fab domain.	0.083	228	191	129	356	4	212	7.248E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6mu3-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6mu3-assembly1.cif.gz_H Anti-HIV-1 Fab 2G12 + Man7 re-refinement	0.098	221	176	136	356	17	212	3.773E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	3o6l-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3o6l-assembly1.cif.gz_H Anti-Tat HIV 11H6H1 Fab' complexed with a 15-mer Tat peptide	0.098	222	175	136	357	17	211	2.874E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6u9s-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	6u9s-assembly2.cif.gz_D Crystal structure of human CD81 large extracellular loop in complex with 5A6 Fab	0.099	226	180	132	357	13	213	2.722E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	5anm-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	5anm-assembly2.cif.gz_D Crystal structure of IgE Fc in complex with a neutralizing antibody	0.091	228	188	129	356	4	211	2.722E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6d01-assembly2.cif.gz_G	LOKIASV2_0429_ESMFold_hypothetical_protein	6d01-assembly2.cif.gz_G Crystal structure of 1210 Fab in complex with circumsporozoite protein NANP5	0.085	225	182	132	356	13	212	2.074E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	4kte-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4kte-assembly1.cif.gz_H Fab fragment of HIV vaccine-elicited CD4bs-directed antibody, GE148, from non-human primate	0.083	216	182	129	344	4	203	4.690E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	4m43-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4m43-assembly1.cif.gz_H Crystal structure of anti-rabies glycoprotein Fab 523-11	0.089	224	179	133	356	16	212	5.229E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	5mvj-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	5mvj-assembly2.cif.gz_A Structure of DC8E8 Fab at pH 6.5 crystallized in space-group P1	0.102	226	177	133	358	16	213	2.442E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	2qqk-assembly1.cif.gz_H-3	LOKIASV2_0429_ESMFold_hypothetical_protein	2qqk-assembly1.cif.gz_H-3 Neuropilin-2 a1a2b1b2 Domains in Complex with a Semaphorin-Blocking Fab	0.087	228	189	129	356	4	211	2.312E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	2vwe-assembly1.cif.gz_L	LOKIASV2_0429_ESMFold_hypothetical_protein	2vwe-assembly1.cif.gz_L Crystal Structure of Vascular Endothelial Growth Factor-B in Complex with a Neutralizing Antibody Fab Fragment	0.074	226	188	132	357	13	216	6.156E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6igu-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6igu-assembly1.cif.gz_H Crystal structure of the hydrolytic antibody Fab 9C10	0.092	221	176	136	356	17	211	1.417E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	5mp3-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	5mp3-assembly2.cif.gz_A Crystal structure of DC8E8 Fab in the complex with a 30-mer tau peptide at pH 6.5	0.085	224	180	133	356	16	213	1.668E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	4aei-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4aei-assembly1.cif.gz_H Crystal structure of the AaHII-Fab4C1 complex	0.093	228	190	129	356	4	213	2.442E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	4cad-assembly3.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4cad-assembly3.cif.gz_H Mechanism of farnesylated CAAX protein processing by the integral membrane protease Rce1	0.083	228	193	129	356	4	214	5.522E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	7o31-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7o31-assembly1.cif.gz_H Crystal structure of the anti-PAS Fab 1.2 in complex with its epitope peptide and the anti-Kappa VHH domain	0.077	228	192	129	356	4	212	1.342E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	2or9-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2or9-assembly1.cif.gz_H The structure of the anti-c-myc antibody 9E10 Fab fragment/epitope peptide complex reveals a novel binding mode dominated by the heavy chain hypervariable loops	0.090	226	190	131	356	6	215	6.501E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	1rih-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1rih-assembly1.cif.gz_H Crystal Structure of Fab 14F7, a unique anti-tumor antibody specific for N-glycolyl GM3	0.078	228	192	129	356	4	212	2.442E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6z2l-assembly1.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	6z2l-assembly1.cif.gz_C Structure of Plasmodium falciparum P113 bound to antibody P3.2	0.098	224	179	133	356	16	214	3.984E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6al5-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6al5-assembly1.cif.gz_H COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB	0.084	228	191	129	356	4	213	3.573E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6dc4-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6dc4-assembly1.cif.gz_H RSV-neutralizing human antibody AM22	0.102	216	178	129	344	4	202	3.035E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	8euq-assembly2.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	8euq-assembly2.cif.gz_I Crystal structure of HLA-DRA*01:01/HLA-DRB1*04:01 in complex with c44H10 Fab	0.082	216	184	129	344	4	204	4.207E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	7kqk-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7kqk-assembly2.cif.gz_H anti-pTau C21-ABS Fab in complex with pTau peptide	0.080	228	193	129	356	4	214	2.312E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	7mrz-assembly1.cif.gz_X	LOKIASV2_0429_ESMFold_hypothetical_protein	7mrz-assembly1.cif.gz_X Structure of GDF11 bound to fused ActRIIB-ECD and Alk4-ECD with Anti-ActRIIB Fab fragment	0.086	226	182	133	358	16	215	3.573E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	1sbs-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1sbs-assembly1.cif.gz_H CRYSTAL STRUCTURE OF AN ANTI-HCG FAB	0.081	221	183	136	356	17	216	6.156E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	1wej-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1wej-assembly1.cif.gz_H IGG1 FAB FRAGMENT (OF E8 ANTIBODY) COMPLEXED WITH HORSE CYTOCHROME C AT 1.8 A RESOLUTION	0.082	229	190	129	357	4	211	5.522E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	5x2n-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5x2n-assembly1.cif.gz_H Crystal structure of the medaka fish taste receptor T1r2a-T1r3 ligand binding domains in complex with L-alanine	0.081	228	194	129	356	4	215	1.668E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	4yue-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4yue-assembly1.cif.gz_H Mouse IL-2 Bound to S4B6 Fab Fragment	0.081	228	195	129	356	4	216	2.190E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6mek-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	6mek-assembly1.cif.gz_B Crystal structure of Hepatitis C virus envelope glycoprotein E2 core in complex with human antibodies HEPC3 and HEPC46	0.086	228	195	129	356	4	217	2.874E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	3ojd-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3ojd-assembly1.cif.gz_B Anti-Indolicidin monoclonal antibody V2D2 (Fab fragment)	0.106	222	180	136	357	17	218	2.312E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6bla-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6bla-assembly1.cif.gz_H Structure of AMM01 Fab, an anti EBV gH/gL neutralizing antibody	0.086	230	197	129	358	4	219	3.384E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	6xpr-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	6xpr-assembly1.cif.gz_B Human antibody D2 H1-1/H3-1 H3 in complex with the influenza hemagglutinin head domain of A/Texas/50/2012(H3N2)	0.089	216	189	129	344	3	210	3.035E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	1opg-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1opg-assembly1.cif.gz_H OPG2 FAB FRAGMENT	0.080	216	188	129	344	4	208	2.312E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	7m42-assembly1.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	7m42-assembly1.cif.gz_D Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of neutralizing antibodies REGN10985 and REGN10989	0.080	214	190	131	344	6	212	1.964E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	7rku-assembly4.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	7rku-assembly4.cif.gz_E Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C022	0.106	221	184	136	356	17	223	1.860E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	7jz4-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	7jz4-assembly2.cif.gz_C Crystal structure of broadly Plasmodium RIFIN reactive LAIR1-inserted antibody MGD21	0.090	413	279	136	548	17	324	2.722E+00	12
LOKIASV2_0429_ESMFold_hypothetical_protein	8gq1-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	8gq1-assembly1.cif.gz_H HyHEL10 Fab complexed with hen egg lysozyme carrying arginine cluster in framework region of light chain.	0.097	228	171	129	356	4	193	2.578E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	1mrf-assembly2.cif.gz_H-2	LOKIASV2_0429_ESMFold_hypothetical_protein	1mrf-assembly2.cif.gz_H-2 PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES	0.077	217	169	140	356	16	199	8.533E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	2z92-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	2z92-assembly1.cif.gz_A Crystal structure of the Fab fragment of anti-ciguatoxin antibody 10C9 in complex with CTX3C_ABCDE	0.080	228	182	129	356	2	200	7.653E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	6o9i-assembly1.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	6o9i-assembly1.cif.gz_D Ternary complex of mouse ECD with Fab1 and Fab2	0.093	219	169	138	356	16	202	3.984E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5dub-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	5dub-assembly1.cif.gz_A Context-independent anti-hypusine antibody FabHpu98 in complex with deoxyhypusine	0.096	228	181	129	356	3	203	3.573E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	3hc0-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	3hc0-assembly2.cif.gz_A BHA10 IgG1 wild-type Fab - antibody directed at human LTBR	0.067	228	186	129	356	4	203	5.830E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	6cxy-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6cxy-assembly1.cif.gz_H Crystal Structure of Human E-cadherin bound by mouse monoclonal antibody Fab mAb-1_19A11	0.108	221	166	136	356	17	203	3.573E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7doh-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7doh-assembly1.cif.gz_H Crystal Structure of GD-26 Fab in Complex with TD Peptide from Haloarcula Marismortui Bacteriorhodopsin I	0.085	228	181	129	356	4	202	6.501E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	4ong-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4ong-assembly1.cif.gz_H Fab fragment of 3D6 in complex with amyloid beta 1-40	0.083	226	181	131	356	6	203	3.984E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5b6f-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	5b6f-assembly1.cif.gz_B Crystal structure of the Fab fragment of an anti-Leukotriene C4 monoclonal antibody complexed with LTC4	0.080	228	185	129	356	3	204	2.874E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5bk5-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5bk5-assembly2.cif.gz_H Crystal structure of the anti-circumsporozoite protein 663 germline antibody	0.080	228	185	131	358	6	207	2.874E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	6ghg-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6ghg-assembly2.cif.gz_H Variable heavy - variable light domain and Fab-arm CrossMabs with charged residue exchanges	0.086	216	173	129	344	4	193	7.653E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7sgm-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7sgm-assembly1.cif.gz_H Crystal structure of a Fab variant containing a fluorescent noncanonical amino acid with blocked excited state proton transfer and in complex with its antigen, CD40L	0.078	216	175	129	344	4	194	5.830E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5bvj-assembly3.cif.gz_F	LOKIASV2_0429_ESMFold_hypothetical_protein	5bvj-assembly3.cif.gz_F The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta	0.084	226	182	131	356	6	205	3.035E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	3eot-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3eot-assembly1.cif.gz_H Crystal structure of LAC031, an engineered anti-VLA1 Fab	0.079	226	182	131	356	6	204	9.010E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	3lex-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	3lex-assembly2.cif.gz_A 2F5 Epitope scaffold elicited anti-HIV-1 monoclonal antibody 11F10 in complex with HIV-1 GP41	0.094	228	181	129	356	4	204	7.248E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7q9f-assembly1.cif.gz_J	LOKIASV2_0429_ESMFold_hypothetical_protein	7q9f-assembly1.cif.gz_J Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein	0.104	207	161	138	344	15	195	5.522E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	4s1d-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	4s1d-assembly2.cif.gz_C Structure of IgG1 Fab fragment in complex with Biotincytidinamide	0.083	223	175	136	358	16	207	4.207E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5tlk-assembly1.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	5tlk-assembly1.cif.gz_D COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191	0.102	230	183	129	358	4	208	3.573E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5tq0-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5tq0-assembly1.cif.gz_H Crystal structure of amino terminal domains of the NMDA receptor subunit GluN1 and GluN2A in the presence of EDTA	0.088	225	176	132	356	13	206	4.442E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	4jre-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4jre-assembly1.cif.gz_H Crystal structure of nitrate/nitrite exchanger NarK with nitrite bound	0.100	215	183	142	356	4	207	9.514E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5tdn-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	5tdn-assembly2.cif.gz_D Crystal structure of the Fab fragment of anti-HER2 antibody 4D5 with redesigned heavy and light chain interfaces	0.078	221	175	136	356	17	207	5.229E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7vgs-assembly1.cif.gz_F	LOKIASV2_0429_ESMFold_hypothetical_protein	7vgs-assembly1.cif.gz_F SARS-CoV-2 M protein dimer (short form) in complex with YN7717_9 Fab	0.081	219	174	138	356	17	206	4.442E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7oxn-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7oxn-assembly1.cif.gz_H Crystal Structure of TAP01 in complex with cyclised amyloid beta peptide	0.088	228	185	129	356	4	207	6.156E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	4s1d-assembly3.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	4s1d-assembly3.cif.gz_E Structure of IgG1 Fab fragment in complex with Biotincytidinamide	0.089	221	174	136	356	17	208	6.501E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7s7i-assembly3.cif.gz_J	LOKIASV2_0429_ESMFold_hypothetical_protein	7s7i-assembly3.cif.gz_J Crystal structure of Fab in complex with MICA alpha3 domain	0.087	221	174	136	356	17	208	2.190E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7su1-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7su1-assembly1.cif.gz_H Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.106 in complex with CTLA-4	0.092	226	183	131	356	6	207	3.384E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7t0j-assembly3.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	7t0j-assembly3.cif.gz_D Crystal structure of S25-2 Fab Unliganded 3	0.100	228	184	129	356	4	208	3.205E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7u5b-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7u5b-assembly1.cif.gz_A Structure of Human KLK5 bound to anti-KLK5 Fab	0.095	216	176	129	344	4	198	5.229E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5vl3-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	5vl3-assembly2.cif.gz_A CD22 d1-d3 in complex with therapeutic Fab Epratuzumab	0.087	221	173	136	356	17	207	5.229E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7zf3-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7zf3-assembly1.cif.gz_A SARS-CoV-2 Omicron RBD in complex with Omi-3 and EY6A Fabs	0.097	221	172	136	356	17	207	2.442E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5do2-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5do2-assembly2.cif.gz_H Complex structure of MERS-RBD bound with 4C2 antibody	0.082	221	173	136	356	17	205	4.207E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7jln-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7jln-assembly1.cif.gz_A Crystal structure of glVRC01 Fab in complex with anti-idiotype iv9 Fab	0.081	224	177	133	356	16	209	3.773E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5kw9-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5kw9-assembly1.cif.gz_H Structural Basis for Norovirus Neutralization by a HBGA Blocking Human IgA Antibody	0.091	193	168	152	344	14	199	7.653E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7l0n-assembly2.cif.gz_M	LOKIASV2_0429_ESMFold_hypothetical_protein	7l0n-assembly2.cif.gz_M Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity	0.060	226	189	131	356	6	207	2.190E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	3okm-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3okm-assembly1.cif.gz_B Crystal structure of unliganded S25-39	0.097	226	182	131	356	6	208	3.205E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	6pis-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6pis-assembly1.cif.gz_H Mouse two pore domain K+ channel TRAAK (K2P4.1) - Fab complex structure	0.080	224	178	133	356	16	209	1.860E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	1plg-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1plg-assembly1.cif.gz_H EVIDENCE FOR THE EXTENDED HELICAL NATURE OF POLYSACCHARIDE EPITOPES. THE 2.8 ANGSTROMS RESOLUTION STRUCTURE AND THERMODYNAMICS OF LIGAND BINDING OF AN ANTIGEN BINDING FRAGMENT SPECIFIC FOR ALPHA-(2->8)-POLYSIALIC ACID	0.075	207	169	138	344	17	200	9.514E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7qt3-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	7qt3-assembly2.cif.gz_C Antibody FenAb609 - fentanyl complex	0.066	219	178	138	356	17	208	6.864E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	6rlm-assembly7.cif.gz_M	LOKIASV2_0429_ESMFold_hypothetical_protein	6rlm-assembly7.cif.gz_M Crystal structure of AT1412dm Fab fragment	0.082	230	188	129	358	5	210	3.384E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7rqr-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7rqr-assembly1.cif.gz_A Structure of chimeric antibody L9heavy_F10light with PfCSP peptide NANPNVDP	0.096	221	174	136	356	17	209	2.442E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	4xaw-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4xaw-assembly1.cif.gz_H Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: Crystals cryoprotected with phosphatidic acid (08:0 PA)	0.084	225	178	133	357	16	210	3.205E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	4xpf-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4xpf-assembly1.cif.gz_H X-ray structure of Drosophila dopamine transporter with subsiteB mutations (D121G/S426M) bound to RTI-55	0.113	223	169	134	356	17	208	3.573E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	6xsw-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6xsw-assembly1.cif.gz_A Structure of the Notch3 NRR in complex with an antibody Fab Fragment	0.071	228	190	129	356	4	208	4.207E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7bm5-assembly5.cif.gz_K	LOKIASV2_0429_ESMFold_hypothetical_protein	7bm5-assembly5.cif.gz_K Crystal structure of Fab1, the Fab fragment of the anti-BamA monoclonal antibody MAB1	0.065	230	194	128	357	3	210	2.312E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	4edx-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4edx-assembly1.cif.gz_H Nerve Growth Factor in Complex with Fab from mouse mAb 911	0.093	221	174	136	356	17	209	5.830E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7ke1-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	7ke1-assembly2.cif.gz_C Factor H enhancing human antibody fragment (Fab) to meningococcal Factor H binding protein	0.087	222	177	136	357	17	211	2.442E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7kgv-assembly1.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	7kgv-assembly1.cif.gz_D Crystal structure of sodium-coupled neutral amino acid transporter SLC38A9 in the N-terminal plugged form	0.110	217	171	140	356	17	209	3.773E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7lr4-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7lr4-assembly2.cif.gz_A Complex of Fab 2/1.12 with domain 3 of P. berghei HAP2	0.080	224	178	133	356	15	209	9.514E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5mv4-assembly5.cif.gz_L	LOKIASV2_0429_ESMFold_hypothetical_protein	5mv4-assembly5.cif.gz_L ACC1 Fab fragment in complex with citrullinated CII616-639 epitope of collagen type II (ptm23)	0.104	228	182	129	356	4	207	8.081E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5nbw-assembly2.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	5nbw-assembly2.cif.gz_B Crystal structure of the Fab fragment 22F12 in complex with 3-hydroxybenzo[a]pyrene	0.076	221	176	136	356	17	207	3.384E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7np1-assembly2.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	7np1-assembly2.cif.gz_I Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-360	0.089	216	179	129	344	4	200	3.205E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	6o3b-assembly2.cif.gz_G	LOKIASV2_0429_ESMFold_hypothetical_protein	6o3b-assembly2.cif.gz_G Crystal structure of Frizzled 7 CRD in complex with F6 Fab	0.084	221	176	136	356	17	209	3.384E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	4plj-assembly1.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	4plj-assembly1.cif.gz_D Hepatitis E Virus E2s domain (Genotype IV) in complex with a neutralizing antibody 8G12	0.083	228	190	129	356	2	209	2.874E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5t1m-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	5t1m-assembly2.cif.gz_D Cetuximab Fab in complex with CQYDLSTRRLKC	0.087	216	178	129	344	4	199	2.190E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	4xbe-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4xbe-assembly1.cif.gz_H Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: crystals cryoprotected with sphingomyelin (02:0 SM (d18:1/2:0)).	0.087	226	179	133	358	16	212	3.384E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7fah-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	7fah-assembly2.cif.gz_C Immune complex of head region of CA09 HA and neutralizing antibody 12H5	0.084	225	180	132	356	13	210	7.653E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7kf1-assembly4.cif.gz_G	LOKIASV2_0429_ESMFold_hypothetical_protein	7kf1-assembly4.cif.gz_G Crystal structure of bH1 Fab variant (CDR H3 loop design 14_0130) in complex with VEGF	0.077	221	178	136	356	17	210	6.864E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	3oke-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3oke-assembly1.cif.gz_B Crystal structure of S25-39 in complex with Ko	0.084	221	177	136	356	17	210	3.035E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	6uig-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6uig-assembly1.cif.gz_H Crystal structure of human monoclonal antibody H7.200 in complex with H7N9 hemagglutinin HA1	0.113	207	165	138	344	17	203	4.207E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7ut3-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7ut3-assembly1.cif.gz_H Crystal structure of complex of Fab, G10C with GalNAc-pNP	0.078	228	190	129	356	4	210	3.573E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	3vfg-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3vfg-assembly1.cif.gz_H Crystal structure of monoclonal antibody 3F8 Fab fragment that binds to GD2 ganglioside	0.069	230	194	129	358	4	212	8.533E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5mp5-assembly3.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	5mp5-assembly3.cif.gz_E Crystal structure of DC8E8 Fab in the complex with a 14-mer tau peptide at pH 6.5	0.101	228	187	129	356	4	212	4.207E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7rth-assembly5.cif.gz_P	LOKIASV2_0429_ESMFold_hypothetical_protein	7rth-assembly5.cif.gz_P Crystal structure of an anti-lysozyme nanobody in complex with an anti-nanobody Fab "NabFab"	0.068	228	192	129	356	5	211	2.074E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	1uwx-assembly2.cif.gz_M	LOKIASV2_0429_ESMFold_hypothetical_protein	1uwx-assembly2.cif.gz_M P1.2 serosubtype antigen derived from N. meningitidis PorA in complex with Fab fragment	0.081	228	189	129	356	3	209	7.248E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	6vor-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	6vor-assembly2.cif.gz_C Crystal structure of macaque anti-HIV-1 antibody RM20E1	0.074	227	184	132	358	13	212	4.952E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5ig7-assembly4.cif.gz_J	LOKIASV2_0429_ESMFold_hypothetical_protein	5ig7-assembly4.cif.gz_J Crystal structure of anti-gliadin 1002-1E01 Fab fragment in complex of peptide PLQPQQPFP	0.097	223	178	136	358	17	214	3.984E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5x2n-assembly2.cif.gz_J	LOKIASV2_0429_ESMFold_hypothetical_protein	5x2n-assembly2.cif.gz_J Crystal structure of the medaka fish taste receptor T1r2a-T1r3 ligand binding domains in complex with L-alanine	0.087	228	190	129	356	4	212	1.964E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	1fsk-assembly1.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	1fsk-assembly1.cif.gz_C COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1	0.094	217	176	140	356	17	211	3.573E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7jxd-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	7jxd-assembly2.cif.gz_C Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology	0.083	216	182	129	344	4	203	3.205E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5kqv-assembly1.cif.gz_P-2	LOKIASV2_0429_ESMFold_hypothetical_protein	5kqv-assembly1.cif.gz_P-2 Insulin receptor ectodomain construct comprising domains L1,CR,L2, FnIII-1 and alphaCT peptide in complex with bovine insulin and FAB 83-14 (REVISED STRUCTURE)	0.093	219	171	138	356	17	206	9.010E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5jo5-assembly4.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	5jo5-assembly4.cif.gz_E Crystal structure of 10E8 gHV-gLV antigen-binding fragment.	0.091	214	180	131	344	6	204	4.207E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	4k3j-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4k3j-assembly1.cif.gz_H Crystal structure of Onartuzumab Fab in complex with MET and HGF-beta	0.086	228	191	129	356	4	213	2.874E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	1mf2-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1mf2-assembly1.cif.gz_H ANTI HIV1 PROTEASE FAB COMPLEX	0.092	228	190	129	356	4	213	3.384E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	6pbw-assembly1.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	6pbw-assembly1.cif.gz_D Crystal structure of Fab667 complex	0.072	230	197	129	358	4	216	4.952E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	2r56-assembly1.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	2r56-assembly1.cif.gz_I Crystal Structure of a Recombinant IgE Fab Fragment in Complex with Bovine Beta-Lactoglobulin Allergen	0.058	214	187	131	344	6	205	7.653E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7rth-assembly4.cif.gz_N	LOKIASV2_0429_ESMFold_hypothetical_protein	7rth-assembly4.cif.gz_N Crystal structure of an anti-lysozyme nanobody in complex with an anti-nanobody Fab "NabFab"	0.090	216	183	129	344	4	205	4.952E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	6xpr-assembly2.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	6xpr-assembly2.cif.gz_E Human antibody D2 H1-1/H3-1 H3 in complex with the influenza hemagglutinin head domain of A/Texas/50/2012(H3N2)	0.100	230	193	129	358	3	217	2.578E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	1wcb-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1wcb-assembly2.cif.gz_H PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN	0.074	228	196	129	356	4	216	7.248E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	2ymx-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2ymx-assembly1.cif.gz_H Crystal structure of inhibitory anti-AChE Fab408	0.073	221	184	136	356	17	215	3.573E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7st8-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7st8-assembly1.cif.gz_H Crystal structure of 7H2.2 Fab in complex with SAS1B C-terminal region	0.080	221	181	136	356	17	214	3.984E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	6uym-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6uym-assembly2.cif.gz_A Structure of Hepatitis C Virus Envelope Glycoprotein E2mc3-v6 redesigned core from genotype 1a bound to broadly neutralizing antibody AR3C	0.093	226	183	133	358	15	217	2.874E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7ora-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7ora-assembly2.cif.gz_H Crystal structure of the T478K mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-45 and COVOX-253 Fabs	0.070	228	196	129	356	4	215	4.952E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	6rcv-assembly1.cif.gz_C-2	LOKIASV2_0429_ESMFold_hypothetical_protein	6rcv-assembly1.cif.gz_C-2 PfRH5 bound to monoclonal antibodies R5.011 and R5.016	0.084	224	182	133	356	16	215	2.312E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	6mam-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6mam-assembly1.cif.gz_A Cleaved Ebola GP in complex with a broadly neutralizing human antibody, ADI-15946	0.076	221	188	136	356	17	220	3.205E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	6v6w-assembly1.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	6v6w-assembly1.cif.gz_I Crystal structure of antibody 438-B11 DSS mutant (Cys98A-100aA) in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22	0.098	225	182	133	357	16	218	3.573E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	6ca6-assembly2.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	6ca6-assembly2.cif.gz_B Crystal structure of PCT64_35S, a broadly neutralizing anti-HIV antibody.	0.074	221	189	136	356	17	221	2.722E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	4fqc-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4fqc-assembly1.cif.gz_H Crystal Structure of PGT121 Fab Bound to a complex-type sialylated N-glycan	0.069	246	196	99	344	1	211	6.864E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	4jm2-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	4jm2-assembly1.cif.gz_A Crystal Structure of PGT 135 Fab in Complex with gp120 Core Protein from HIV-1 Strain JR-FL Bound to CD4 and 17b Fab	0.084	221	186	136	356	17	220	4.207E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	7kyl-assembly2.cif.gz_X	LOKIASV2_0429_ESMFold_hypothetical_protein	7kyl-assembly2.cif.gz_X Powassan virus Envelope protein DIII in complex with neutralizing Fab POWV-80	0.081	226	194	131	356	6	217	6.501E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	2or9-assembly2.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	2or9-assembly2.cif.gz_I The structure of the anti-c-myc antibody 9E10 Fab fragment/epitope peptide complex reveals a novel binding mode dominated by the heavy chain hypervariable loops	0.094	226	194	131	356	6	220	4.207E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	3u46-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3u46-assembly1.cif.gz_H CH04H/CH02L P212121	0.086	221	187	136	356	17	222	3.773E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5c8j-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	5c8j-assembly2.cif.gz_C A YidC-like protein in the archaeal plasma membrane	0.094	216	187	129	344	5	211	3.573E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	5d1z-assembly3.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	5d1z-assembly3.cif.gz_D IsdB NEAT1 bound by clone D4-10	0.084	224	189	133	356	16	222	3.384E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	3twc-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3twc-assembly1.cif.gz_H Crystal structure of broad and potent HIV-1 neutralizing antibody PGT127 in complex with Man9	0.070	216	193	129	344	4	212	5.522E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	4yaq-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	4yaq-assembly2.cif.gz_A Crystal structure of a computationally optimized PG9 mutant	0.087	216	194	131	344	5	220	2.874E+00	11
LOKIASV2_0429_ESMFold_hypothetical_protein	6j15-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6j15-assembly2.cif.gz_H Complex structure of GY-5 Fab and PD-1	0.092	215	166	142	356	14	197	4.952E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6bi0-assembly2.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	6bi0-assembly2.cif.gz_I Trastuzumab Fab N158A, D185A, K190A (Light Chain) Triple Mutant.	0.085	216	171	129	344	4	191	8.081E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	4gay-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	4gay-assembly2.cif.gz_A Structure of the broadly neutralizing antibody AP33	0.102	221	166	136	356	16	201	3.984E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	4otx-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4otx-assembly1.cif.gz_H Structure of the anti-Francisella tularensis O-antigen antibody N203 Fab fragment	0.060	228	184	129	356	4	200	5.522E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	3ujt-assembly2.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	3ujt-assembly2.cif.gz_I Structure of the Fab fragment of Ab-52, an antibody that binds the O-antigen of Francisella tularensis	0.083	219	168	138	356	17	200	6.501E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6mh2-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	6mh2-assembly1.cif.gz_B Structure of Herceptin Fab without antigen	0.076	214	172	131	344	6	192	6.864E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7tqb-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7tqb-assembly1.cif.gz_H Crystal structure of monoclonal S9.6 Fab bound to DNA-RNA hybrid	0.053	228	189	129	356	4	204	6.156E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6hf1-assembly1.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	6hf1-assembly1.cif.gz_C Mutant oxidoreductase fragment of mouse QSOX1 in complex with an antibody Fab	0.083	216	173	129	344	4	193	6.864E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6lhc-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6lhc-assembly1.cif.gz_A The cryo-EM structure of coxsackievirus A16 empty particle	0.130	162	125	77	221	6	167	4.690E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6mv5-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6mv5-assembly1.cif.gz_H Anti-PCSK9 fab 6E2 bound to the N-terminal peptide from PCSK9 (E32K)	0.082	228	182	129	356	4	202	5.522E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6p4a-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6p4a-assembly1.cif.gz_H HyHEL10 Fab complexed with hen egg lysozyme carrying two mutations (HEL2x-rigid): R21Q and R73E	0.103	221	164	136	356	17	200	7.248E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7e88-assembly3.cif.gz_G	LOKIASV2_0429_ESMFold_hypothetical_protein	7e88-assembly3.cif.gz_G Crystal structure of the SARS-CoV-2 S RBD in complex with BD-515 Fab	0.097	221	170	136	356	16	204	6.864E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6qu9-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6qu9-assembly2.cif.gz_A Fab fragment of an antibody that inhibits polymerisation of alpha-1-antitrypsin	0.107	228	178	129	356	4	203	4.690E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6aod-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	6aod-assembly1.cif.gz_B FXIa antibody complex	0.052	224	178	133	356	16	204	7.653E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6ev1-assembly3.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	6ev1-assembly3.cif.gz_E Crystal structure of antibody against schizophyllan	0.048	228	190	129	356	4	204	4.207E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6rlo-assembly3.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	6rlo-assembly3.cif.gz_E Crystal structure of AT1412dm Fab fragment in complex with CD9 large extracellular loop	0.108	217	172	142	358	14	207	5.522E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	2v7n-assembly4.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2v7n-assembly4.cif.gz_H Unusual twinning in crystals of the CitS binding antibody Fab fragment f3p4	0.077	214	175	131	344	5	195	5.830E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7w71-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7w71-assembly2.cif.gz_H Crystal structure of the PDZ-C domain of E. coli RseP in complex with 12C7 Fab	0.079	224	172	133	356	16	203	9.514E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	3w9d-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	3w9d-assembly2.cif.gz_C Structure of Human Monoclonal Antibody E317 Fab	0.084	221	172	136	356	17	205	4.207E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	5xs5-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	5xs5-assembly1.cif.gz_A Structure of Coxsackievirus A6 (CVA6) virus procapsid particle	0.074	159	116	96	221	13	171	6.156E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6yhq-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6yhq-assembly1.cif.gz_H Crystal Structure of Fab F5.18.6, anti-Plasmodium vivax AMA1	0.086	226	181	131	356	6	204	4.952E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6b5t-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6b5t-assembly1.cif.gz_H Structure of PfCSP peptide 29 with human antibody CIS42	0.089	207	163	138	344	17	196	3.773E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	4isv-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	4isv-assembly1.cif.gz_B Crystal structure of the Fab FRAGMENT OF 1C2, A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE	0.089	228	183	129	356	4	205	4.690E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6lhb-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6lhb-assembly1.cif.gz_A The cryo-EM structure of coxsackievirus A16 A-particle	0.128	158	128	74	221	13	170	5.522E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6nov-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	6nov-assembly2.cif.gz_C A Fab derived from ixekizumab	0.071	228	188	129	356	4	206	3.384E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6u8c-assembly1.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	6u8c-assembly1.cif.gz_D Crystal structure of an engineered ultra-high affinity Fab-Protein G complex	0.079	228	185	129	356	4	205	4.690E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	2xzc-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2xzc-assembly1.cif.gz_H Crystal Structure of phosphonate-modified recombinant A.17 antibody FAB fragment	0.062	229	190	129	357	4	207	5.522E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7fgk-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7fgk-assembly1.cif.gz_H The Fab antibody single structure against tau protein.	0.078	230	189	129	358	4	209	6.156E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	1kfa-assembly3.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1kfa-assembly3.cif.gz_H Crystal structure of Fab fragment complexed with gibberellin A4	0.078	228	186	129	356	3	205	3.384E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	4llw-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	4llw-assembly1.cif.gz_A Crystal structure of Pertuzumab Clambda Fab with variable domain redesign (VRD2) at 1.95A	0.068	216	179	129	344	4	196	5.229E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	5mhr-assembly2.cif.gz_P	LOKIASV2_0429_ESMFold_hypothetical_protein	5mhr-assembly2.cif.gz_P T3D reovirus sigma1 complexed with 9BG5 Fab fragments	0.082	224	176	133	356	16	208	6.501E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7sgm-assembly1.cif.gz_K	LOKIASV2_0429_ESMFold_hypothetical_protein	7sgm-assembly1.cif.gz_K Crystal structure of a Fab variant containing a fluorescent noncanonical amino acid with blocked excited state proton transfer and in complex with its antigen, CD40L	0.085	228	186	129	356	4	207	5.830E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6u36-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6u36-assembly1.cif.gz_H PCSK9 in complex with a Fab and compound 14	0.070	226	187	131	356	6	207	9.514E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6ev1-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	6ev1-assembly2.cif.gz_C Crystal structure of antibody against schizophyllan	0.064	228	188	129	356	4	205	3.773E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7f6z-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7f6z-assembly1.cif.gz_H Complex Structure of antibody BD-503 and RBD-501Y.V2 of COVID-19	0.078	228	186	129	356	4	206	9.514E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	4jfy-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	4jfy-assembly1.cif.gz_B Apo structure of phosphotyrosine (pYAb) scaffold	0.087	216	176	129	344	4	197	3.773E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6w5d-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6w5d-assembly2.cif.gz_A Crystal Structure of Fab RSB1	0.081	207	166	138	344	17	198	3.205E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6xc3-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	6xc3-assembly1.cif.gz_B Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.1 and CR3022	0.081	214	175	131	344	6	196	3.984E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7z2m-assembly1.cif.gz_F	LOKIASV2_0429_ESMFold_hypothetical_protein	7z2m-assembly1.cif.gz_F Crystal Structure of the 11.003 Fab in complex with human IL-17A	0.075	230	190	129	358	4	209	4.442E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	4zyk-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4zyk-assembly1.cif.gz_H Crystal Structure of Quaternary-Specific RSV-Neutralizing Human Antibody AM14	0.077	209	168	136	344	16	198	5.522E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	8db4-assembly1.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	8db4-assembly1.cif.gz_C Crystal structure of the peanut allergen Ara h 2 bound by two neutralizing antibodies 22S1 and 13T1	0.098	228	185	131	358	6	211	3.205E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6hgu-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6hgu-assembly2.cif.gz_H Crystal Structure of an anti-APP-tag Fab	0.097	219	172	138	356	17	208	9.514E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	5mv3-assembly4.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	5mv3-assembly4.cif.gz_I ACC1 Fab fragment in complex with CII583-591 (CG10)	0.072	228	187	129	356	4	206	8.533E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7or9-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7or9-assembly1.cif.gz_A Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and COVOX-278 Fabs	0.079	228	188	129	356	4	208	4.952E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7t0l-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7t0l-assembly1.cif.gz_H HLA-B*27:05 in complex with the pan-HLA-Ia monoclonal antibody W6/32	0.082	226	190	131	356	5	212	3.573E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7v8q-assembly3.cif.gz_F	LOKIASV2_0429_ESMFold_hypothetical_protein	7v8q-assembly3.cif.gz_F Crystal structure of antibody 14A in complex with MUC1 Glycopeptide(GlycoT)	0.083	214	175	131	344	6	197	7.653E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	5drx-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	5drx-assembly2.cif.gz_A Crystal structure of the BCR Fab fragment from subset #4 case CLL240	0.103	216	176	129	344	4	200	3.205E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6h0e-assembly4.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	6h0e-assembly4.cif.gz_E FAB dmCBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-23	0.082	216	180	129	344	4	200	5.830E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	3iu4-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3iu4-assembly1.cif.gz_H anti NeuGcGM3 ganglioside chimeric antibody chP3	0.082	216	179	129	344	4	199	3.573E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	4m7z-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	4m7z-assembly1.cif.gz_B Unliganded 1 crystal structure of S25-26 Fab	0.109	215	173	142	356	14	208	6.864E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	1ngy-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	1ngy-assembly1.cif.gz_B Chimeric Mature Fab 7g12-Apo	0.096	219	173	138	356	17	208	8.081E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	2qr0-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	2qr0-assembly1.cif.gz_B Structure of VEGF complexed to a Fab containing TYR and SER in the CDRs	0.083	227	185	131	357	6	208	3.573E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7qt0-assembly1.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	7qt0-assembly1.cif.gz_C Antibody FenAb136 - fentanyl complex	0.080	219	178	138	356	17	210	4.442E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	4xmk-assembly3.cif.gz_J	LOKIASV2_0429_ESMFold_hypothetical_protein	4xmk-assembly3.cif.gz_J Crystal structure of Fab of HIV-1 gp120 V3-specific human monoclonal antibody 2424 in complex with JR-FL V3 peptide	0.069	221	180	136	356	17	210	3.984E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	5y9k-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5y9k-assembly1.cif.gz_H Structure of the belimumab Fab fragment	0.069	212	171	133	344	15	199	4.207E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6dez-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6dez-assembly1.cif.gz_H Anti-phosphotyrosine antibody PY20-4D5 Fab complexed with sulfate	0.079	217	182	129	345	4	202	3.035E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6dg2-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6dg2-assembly1.cif.gz_A Antigen Binding Fragment of the Pan-ebolavirus Monoclonal Antibody 6D6	0.089	212	167	133	344	16	199	5.229E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	1hkl-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1hkl-assembly1.cif.gz_H FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY	0.080	228	188	129	356	4	208	6.156E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7k76-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7k76-assembly2.cif.gz_H Crystal structure of MAD2-6 IgG Fab in complex with PfCSP N-terminal peptide.	0.097	209	165	136	344	17	200	3.205E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7ke1-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7ke1-assembly1.cif.gz_A Factor H enhancing human antibody fragment (Fab) to meningococcal Factor H binding protein	0.082	228	190	129	356	4	211	4.442E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7kgv-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	7kgv-assembly2.cif.gz_C Crystal structure of sodium-coupled neutral amino acid transporter SLC38A9 in the N-terminal plugged form	0.100	223	176	134	356	15	210	6.156E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	2rcs-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2rcs-assembly1.cif.gz_H IMMUNOGLOBULIN 48G7 GERMLINE FAB-AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY	0.087	224	175	133	356	16	208	9.010E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7t1w-assembly5.cif.gz_H5	LOKIASV2_0429_ESMFold_hypothetical_protein	7t1w-assembly5.cif.gz_H5 Crystal structure of human Fab A194-01 in complex with its synthetic tetrasaccharide Ara4 epitope (BSI110886)	0.099	221	174	136	356	17	210	4.442E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	5x2m-assembly2.cif.gz_J	LOKIASV2_0429_ESMFold_hypothetical_protein	5x2m-assembly2.cif.gz_J Crystal structure of the medaka fish taste receptor T1r2a-T1r3 ligand binding domains in complex with L-glutamine	0.094	228	187	129	356	4	210	4.207E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	5xmh-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5xmh-assembly1.cif.gz_H Crystal structure of an IgM rheumatoid factor YES8c in complex with IgG1 Fc	0.088	230	191	129	358	4	213	9.010E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7ew5-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	7ew5-assembly1.cif.gz_B immune complex of HPV6 L1 pentamer and neutralizing antibody 13H5	0.090	224	180	133	356	14	212	6.156E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	3j2y-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3j2y-assembly1.cif.gz_B Electron Cryo-microscopy of Chikungunya VLP in complex with neutralizing antibody Fab 9.8B	0.082	221	178	136	356	17	211	7.653E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	5mp5-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	5mp5-assembly1.cif.gz_A Crystal structure of DC8E8 Fab in the complex with a 14-mer tau peptide at pH 6.5	0.098	228	187	129	356	4	211	3.773E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	3oau-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3oau-assembly1.cif.gz_H Antibody 2G12 Recognizes Di-Mannose Equivalently in Domain- and Non-Domain-Exchanged Forms, but only binds the HIV-1 Glycan Shield if Domain-Exchanged	0.088	214	178	131	344	6	201	6.864E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	4plk-assembly2.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	4plk-assembly2.cif.gz_I Hepatitis E Virus E2s domain (Genotype I) in complex with a neutralizing antibody 8G12	0.054	226	196	131	356	4	211	3.573E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7q0g-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7q0g-assembly1.cif.gz_H Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-49 and FI-3A Fabs	0.084	228	190	129	356	4	211	5.229E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	2wuc-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2wuc-assembly1.cif.gz_H Crystal structure of HGFA in complex with the allosteric non- inhibitory antibody Fab40.deltaTrp and Ac-KQLR-chloromethylketone	0.084	228	188	129	356	4	209	9.514E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	5x2p-assembly2.cif.gz_J	LOKIASV2_0429_ESMFold_hypothetical_protein	5x2p-assembly2.cif.gz_J Crystal structure of the medaka fish taste receptor T1r2a-T1r3 ligand binding domains in complex with L-glutamate	0.073	228	192	129	356	4	211	3.573E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6x78-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	6x78-assembly1.cif.gz_B Vaccine-elicited mouse FP-targeting neutralizing antibody vFP48.03 in complex with HIV fusion peptide (residue 512-519)	0.086	224	177	133	356	16	210	6.501E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7yxu-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7yxu-assembly1.cif.gz_H Crystal structure of agonistic antibody 1618 fab domain bound to human 4-1BB.	0.075	228	191	129	356	4	210	3.573E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	3o2v-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3o2v-assembly1.cif.gz_H Crystal structure of 1E9 PheL89Ser/LeuH47Trp/MetH100bPhe, an engineered Diels-Alderase Fab with modified specificity and catalytic activity	0.080	228	192	129	356	4	213	3.573E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	4rir-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4rir-assembly1.cif.gz_H Structural Analysis of the Unmutated Ancestor of the HIV-1 Envelope V2 Region Antibody CH58 Isolated From an RV144 HIV-1 Vaccine Efficacy Trial Vaccinee and Associated with Decreased Transmission Risk	0.077	213	175	132	344	13	203	2.578E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7u2e-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7u2e-assembly1.cif.gz_H Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADI-55688	0.070	214	181	131	344	6	201	3.773E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6wk4-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6wk4-assembly1.cif.gz_A Fab Fragment of Anti-human LAG3 antibody (13E2)	0.092	207	168	138	344	17	202	6.501E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	5x2m-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5x2m-assembly1.cif.gz_H Crystal structure of the medaka fish taste receptor T1r2a-T1r3 ligand binding domains in complex with L-glutamine	0.095	228	188	129	356	4	212	4.207E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7z0y-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7z0y-assembly1.cif.gz_H THSC20.HVTR04 Fab bound to SARS-CoV-2 Receptor Binding Domain	0.090	226	187	131	356	6	212	5.229E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	4hc1-assembly2.cif.gz_M	LOKIASV2_0429_ESMFold_hypothetical_protein	4hc1-assembly2.cif.gz_M Crystal structure of a loop deleted mutant of human MAdCAM-1 D1D2 complexed with Fab 10G3	0.094	225	178	133	357	16	212	9.010E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	3hr5-assembly1.cif.gz_J	LOKIASV2_0429_ESMFold_hypothetical_protein	3hr5-assembly1.cif.gz_J M1prime peptide from IgE bound by humanized antibody 47H4 Fab	0.087	228	189	129	356	4	211	5.229E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	3lrs-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3lrs-assembly1.cif.gz_H Structure of PG16, an antibody with broad and potent neutralization of HIV-1	0.080	221	181	136	356	17	214	6.864E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7tcn-assembly1.cif.gz_G	LOKIASV2_0429_ESMFold_hypothetical_protein	7tcn-assembly1.cif.gz_G Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.SOSIP.664 with high-mannose glycans	0.098	228	187	131	358	6	213	4.952E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7ucf-assembly1.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	7ucf-assembly1.cif.gz_D Structure of the BG505 SOSIP.664 trimer in complex with neutralizing antibody Fab fragments 10-1074 and BG24	0.078	221	179	136	356	17	211	2.578E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	1yy9-assembly1.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	1yy9-assembly1.cif.gz_D Structure of the extracellular domain of the epidermal growth factor receptor in complex with the Fab fragment of cetuximab/Erbitux/IMC-C225	0.082	228	192	129	356	4	213	3.984E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	2bmk-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2bmk-assembly2.cif.gz_H Fab fragment of PLP-dependent catalytic antibody 15A9 in complex with phosphopyridoxyl-D-alanine	0.077	228	194	129	356	4	214	4.690E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	3ghe-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3ghe-assembly1.cif.gz_H Crystal structure of anti-HIV-1 Fab 537-10D in complex with V3 peptide MN	0.078	214	184	131	344	6	206	4.952E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6qkd-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6qkd-assembly1.cif.gz_H CRYSTAL STRUCTURE OF vhh-based FAB-fragment of antibody BCD-085	0.125	203	168	142	344	13	205	6.864E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7s1b-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7s1b-assembly1.cif.gz_H Crystal structure of Epstein-Barr virus glycoproteins gH/gL/gp42-peptide in complex with human neutralizing antibodies 769C2 and 770F7	0.112	222	177	136	357	17	216	3.984E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	3sob-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3sob-assembly1.cif.gz_H The structure of the first YWTD beta propeller domain of LRP6 in complex with a FAB	0.097	216	182	129	344	4	205	3.773E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7coe-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7coe-assembly1.cif.gz_H Crystal structure of Receptor binding domain of MERS-CoV and KNIH90-F1 Fab complex	0.073	228	197	129	356	4	216	5.229E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	8oxx-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	8oxx-assembly1.cif.gz_B Transglutaminase 3 in complex with inhibitor Z-don and DH patient-derived Fab DH63-B02	0.087	214	183	131	344	6	206	4.207E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	4rqp-assembly1.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	4rqp-assembly1.cif.gz_E Crystal structure of the natually occurring empty particle of a clinical C4 strain EV71	0.078	282	176	96	377	14	205	4.952E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	4qww-assembly1.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	4qww-assembly1.cif.gz_D Crystal structure of the Fab410-BfAChE complex	0.088	228	195	129	356	4	218	4.442E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7s5r-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7s5r-assembly1.cif.gz_H Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16	0.065	228	199	129	356	4	217	3.573E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	8gv4-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	8gv4-assembly1.cif.gz_A A human broadly neutralizing influenza A hemagglutinin stem-specific antibody PN-SIA28	0.089	216	187	129	344	4	209	4.207E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	5eu7-assembly1.cif.gz_F	LOKIASV2_0429_ESMFold_hypothetical_protein	5eu7-assembly1.cif.gz_F Crystal structure of HIV-1 integrase catalytic core in complex with Fab	0.091	214	185	131	344	6	209	3.573E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	2hwz-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2hwz-assembly1.cif.gz_H Fab fragment of Humanized anti-viral antibody MEDI-493 (Synagis TM)	0.105	209	167	136	344	17	204	8.081E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	7mnl-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7mnl-assembly1.cif.gz_H Crystal structure of the N-terminal domain of NUP358/RanBP2 (residues 1-752) in complex with Fab fragment	0.080	228	201	129	356	4	223	6.501E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	3mlw-assembly2.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	3mlw-assembly2.cif.gz_I Crystal structure of anti-HIV-1 V3 Fab 1006-15D in complex with an MN V3 peptide	0.085	212	179	133	344	14	210	5.522E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	5c8j-assembly4.cif.gz_G	LOKIASV2_0429_ESMFold_hypothetical_protein	5c8j-assembly4.cif.gz_G A YidC-like protein in the archaeal plasma membrane	0.067	216	194	129	344	4	212	8.533E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	3tje-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3tje-assembly1.cif.gz_H Crystal structure of Fas receptor extracellular domain in complex with Fab E09	0.102	209	173	136	344	17	210	3.984E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6utk-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6utk-assembly1.cif.gz_H Crystal structure of 438-B11 Fab in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22 at 3.80 Angstrom	0.093	225	188	133	357	16	223	5.522E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	4ocr-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4ocr-assembly1.cif.gz_H Crystal structure of human Fab CAP256-VRC26.01, a potent V1V2-directed HIV-1 neutralizing antibody	0.089	214	189	131	344	6	214	3.984E+00	10
LOKIASV2_0429_ESMFold_hypothetical_protein	6acw-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6acw-assembly1.cif.gz_A The structure of CVA10 virus procapsid particle	0.084	290	180	124	413	5	201	3.773E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	4xxd-assembly2.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	4xxd-assembly2.cif.gz_E Crystal Structure of mid-region amyloid beta capture by solanezumab	0.070	228	182	129	356	3	199	4.690E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	5vjq-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	5vjq-assembly1.cif.gz_A Complex between HyHEL10 Fab fragment heavy chain mutant (I29F, S52T, Y53F) and Pekin duck egg lysozyme isoform I (DEL-I)	0.075	228	182	129	356	4	201	7.653E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	3s37-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3s37-assembly1.cif.gz_H Structural basis for the function of two anti-VEGF receptor antibodies	0.097	224	172	133	356	13	203	6.864E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7wsl-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7wsl-assembly1.cif.gz_H PD-1 in complex with Dostarlimab	0.080	221	171	136	356	17	203	6.864E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	5f6h-assembly2.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	5f6h-assembly2.cif.gz_I Crystal Structure of Tier 2 Neutralizing Antibody DH427 from a Rhesus Macaque	0.078	228	184	129	356	4	204	4.207E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7xs8-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7xs8-assembly1.cif.gz_A Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P5S-1H1 Fab	0.090	228	183	129	356	3	204	5.522E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6ev1-assembly4.cif.gz_G	LOKIASV2_0429_ESMFold_hypothetical_protein	6ev1-assembly4.cif.gz_G Crystal structure of antibody against schizophyllan	0.055	228	189	129	356	4	204	4.952E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	5f3h-assembly2.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	5f3h-assembly2.cif.gz_E Structure of myostatin in complex with humanized RK35 antibody	0.081	216	176	129	344	4	195	8.081E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	5i18-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5i18-assembly1.cif.gz_H CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV4-1	0.065	230	191	129	358	3	207	5.522E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7lka-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7lka-assembly2.cif.gz_A Crystal structure of SARS-CoV-2 RBD-targeting antibody COV107-23	0.083	221	173	136	356	16	205	4.952E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6rlo-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	6rlo-assembly2.cif.gz_C Crystal structure of AT1412dm Fab fragment in complex with CD9 large extracellular loop	0.100	217	173	142	358	14	206	7.653E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	5tkj-assembly4.cif.gz_J	LOKIASV2_0429_ESMFold_hypothetical_protein	5tkj-assembly4.cif.gz_J Structure of vaccine-elicited diverse HIV-1 neutralizing antibody vFP1.01 in complex with HIV-1 fusion peptide residue 512-519	0.084	228	184	129	356	4	205	6.156E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	8dgv-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	8dgv-assembly1.cif.gz_H Crystal structure of MERS-CoV spike stem helix peptide in complex with Fab of broadly neutralizing antibody CC99.103 isolated from a vaccinated COVID-19 convalescent	0.080	216	177	129	344	4	196	6.864E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	8f0l-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	8f0l-assembly1.cif.gz_A Crystal Structure of the Human T cell Receptor CD3(EPSILON) N-Terminal Peptide Complexed with ADI-26906 FAB	0.067	228	188	129	356	4	206	6.156E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	4g7y-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4g7y-assembly1.cif.gz_H Crystal structure of voltage sensing domain of Ci-VSP with fragment antibody (R217E, 2.8 A)	0.080	228	186	129	356	4	206	4.442E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6jc2-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6jc2-assembly1.cif.gz_H Crystal structure of the Fab fragment of ipilimumab	0.078	228	186	129	356	4	206	8.533E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7ox2-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7ox2-assembly1.cif.gz_A Fab 6E2: hIL-9 complex	0.085	209	162	136	344	17	194	5.830E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	1s3k-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1s3k-assembly1.cif.gz_H Crystal Structure of a Humanized Fab (hu3S193) in Complex with the Lewis Y Tetrasaccharide	0.074	226	185	131	356	6	206	6.156E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	3hi6-assembly3.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3hi6-assembly3.cif.gz_H Crystal structure of intermediate affinity I domain of integrin LFA-1 with the Fab fragment of its antibody AL-57	0.079	228	187	129	356	4	207	4.207E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6kva-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6kva-assembly1.cif.gz_H Structure of anti-hCXCR2 abN48-2 in complex with its CXCR2 epitope	0.073	216	179	129	344	4	197	9.010E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7lse-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7lse-assembly1.cif.gz_H Crystal structure of the human neutralizing antibody Fab fragment T025 bound to TBEV EDIII (Far Eastern Subtype)	0.080	226	185	131	356	6	207	4.952E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7rlv-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7rlv-assembly1.cif.gz_A Antibody 2F2 in complex with P. vivax CSP peptide GDRADGQPAGDRADGQPA	0.081	221	176	136	356	15	206	3.984E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7uds-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7uds-assembly1.cif.gz_H Structure of lineage I (Pinneo) Lassa virus glycoprotein bound to Fab 25.10C	0.088	230	188	129	358	2	208	8.533E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6bzy-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6bzy-assembly1.cif.gz_H Structure of the Hepatitis C virus envelope glycoprotein E2 antigenic region 412-423 bound to the 22D11 broadly neutralizing antibody	0.076	221	176	136	356	17	207	6.156E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6c08-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	6c08-assembly2.cif.gz_D Zebrafish SLC38A9 with arginine bound in the cytosol open state	0.090	221	174	136	356	17	208	6.156E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	5eoc-assembly2.cif.gz_J	LOKIASV2_0429_ESMFold_hypothetical_protein	5eoc-assembly2.cif.gz_J Crystal structure of Fab C2 in complex with a Cyclic variant of Hepatitis C Virus E2 epitope I	0.091	219	174	138	356	16	207	7.653E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	3fo1-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3fo1-assembly1.cif.gz_B Crystal structure of hapten complex of catalytic elimination antibody 13G5 (Glu(L39)Ala mutant)	0.082	209	166	136	344	17	198	6.156E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6hhc-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6hhc-assembly1.cif.gz_H Allosteric Inhibition as a new mode of Action for BAY 1213790, a Neutralizing Antibody Targeting the Activated form of Coagulation Factor XI	0.082	226	185	131	356	6	207	6.156E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6ldx-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6ldx-assembly1.cif.gz_H Structure antibody E6 in complex with methylated peptide	0.085	228	185	129	356	5	207	8.533E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	5mp1-assembly1.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	5mp1-assembly1.cif.gz_C Crystal structure of DC8E8 Fab in the complex with a 14-mer tau peptide at pH 7.5	0.098	221	172	136	356	16	207	8.081E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	3o2w-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3o2w-assembly1.cif.gz_H Crystal structure of the 1E9 PheL89Ser/LeuH47Trp/MetH100bPhe Fab in complex with a 39A11 transition state analog	0.081	228	187	129	356	4	208	6.156E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6vbp-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6vbp-assembly1.cif.gz_H Crystal structure of anti-HIV-1 antibody DH815 bound to gp120 V2 peptide	0.082	226	179	132	357	13	208	7.653E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6xlz-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6xlz-assembly1.cif.gz_H Structure of NHP D11A.F2 Fab in complex with 16055 V2b peptide	0.102	216	173	129	344	4	197	6.156E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6yxl-assembly1.cif.gz_HHH	LOKIASV2_0429_ESMFold_hypothetical_protein	6yxl-assembly1.cif.gz_HHH Crystal structure of ACPA F3	0.083	222	176	136	357	17	209	4.690E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	4c83-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	4c83-assembly2.cif.gz_A Crystal Structure of the IgG2a LPT3 in complex with an 8-sugar inner core analogue of Neisseria meningitidis	0.082	226	185	131	356	5	206	6.156E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	5d96-assembly1.cif.gz_J	LOKIASV2_0429_ESMFold_hypothetical_protein	5d96-assembly1.cif.gz_J Oxidoreductase Fragment of Mouse QSOX1 in Complex with a FAb Fragment from an Antibody Targeting Mouse and Human QSOX1	0.083	228	185	129	356	4	206	4.442E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6ev2-assembly4.cif.gz_G	LOKIASV2_0429_ESMFold_hypothetical_protein	6ev2-assembly4.cif.gz_G Crystal structure of antibody against schizophyllan in complex with laminarihexaose	0.075	219	175	138	356	17	206	5.229E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	1ngq-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1ngq-assembly1.cif.gz_H N1G9 (IGG1-LAMBDA) FAB FRAGMENT	0.075	221	177	136	356	17	208	9.010E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	4nhg-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	4nhg-assembly1.cif.gz_A Crystal Structure of 2G12 IgG Dimer	0.075	226	187	131	356	6	208	9.514E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7ce2-assembly1.cif.gz_Z	LOKIASV2_0429_ESMFold_hypothetical_protein	7ce2-assembly1.cif.gz_Z The Crystal structure of TeNT Hc complexed with neutralizing antibody	0.108	227	175	132	358	13	209	5.229E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	3fo1-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3fo1-assembly2.cif.gz_H Crystal structure of hapten complex of catalytic elimination antibody 13G5 (Glu(L39)Ala mutant)	0.090	209	167	136	344	17	200	4.442E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	2g5b-assembly4.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	2g5b-assembly4.cif.gz_H Crystal Structure of the anti-Bax monoclonal antibody 6A7 and a Bax peptide.	0.080	228	190	129	356	4	210	6.156E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7o9s-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7o9s-assembly1.cif.gz_H Hantaan virus Gn in complex with Fab nnHTN-Gn2	0.112	225	174	132	356	13	209	6.156E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7stz-assembly1.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	7stz-assembly1.cif.gz_I Crystal Structure of Human E-cadherin EC1-5 bound by mouse monoclonal antibody Fab mAb-1_19A11	0.087	228	186	129	356	4	208	7.248E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7v5n-assembly1.cif.gz_F	LOKIASV2_0429_ESMFold_hypothetical_protein	7v5n-assembly1.cif.gz_F Crystal structure of Fab fragment of bevacizumab bound to DNA aptamer	0.085	228	188	129	356	4	210	7.653E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	5w06-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5w06-assembly1.cif.gz_H HUMAN TISSUE FACTOR IN COMPLEX WITH ANTIBODY M1587	0.068	224	182	133	356	14	209	6.156E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	4xnm-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	4xnm-assembly1.cif.gz_B Antibody Influenza H5 Complex	0.092	207	166	138	344	17	200	9.010E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	3zkn-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3zkn-assembly2.cif.gz_H BACE2 FAB INHIBITOR COMPLEX	0.081	221	176	136	356	17	209	6.501E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	5fcu-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5fcu-assembly1.cif.gz_H CRYSTAL STRUCTURE OF THE INNER DOMAIN OF CLADE A/E HIV-1 GP120 IN COMPLEX WITH THE ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4	0.108	209	164	136	344	17	201	6.864E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6o1f-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6o1f-assembly1.cif.gz_H Complex between soybean trypsin inhibitor beta1-tryptase and a humanized fab	0.079	221	176	136	356	17	208	6.864E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6o9i-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6o9i-assembly1.cif.gz_A Ternary complex of mouse ECD with Fab1 and Fab2	0.093	221	174	136	356	17	209	8.081E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7ycl-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7ycl-assembly2.cif.gz_H Crystal structure of SARS-CoV-2 Spike RBD in complex with IS-9A Fab	0.086	225	179	132	356	13	209	5.830E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7ams-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7ams-assembly1.cif.gz_H Crystal structure of the complex of the KFN mutant of HuJovi-1 Fab with human TRBC2	0.070	228	193	129	356	4	211	4.952E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	3d0l-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	3d0l-assembly1.cif.gz_B Crystal structure of the HIV-1 broadly neutralizing antibody 2F5 in complex with the gp41 FP-MPER Hyb3K construct 514GIGALFLGFLGAAGS528KK-Ahx-655KNEQELLELDKWASLWN671	0.076	216	183	129	344	4	202	9.514E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	8db4-assembly2.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	8db4-assembly2.cif.gz_I Crystal structure of the peanut allergen Ara h 2 bound by two neutralizing antibodies 22S1 and 13T1	0.112	226	182	131	356	6	211	5.522E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7jmp-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7jmp-assembly1.cif.gz_H Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39	0.084	214	180	131	344	5	201	5.229E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	3kr3-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3kr3-assembly1.cif.gz_H Crystal structure of IGF-II antibody complex	0.091	221	176	136	356	17	211	9.514E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6o25-assembly3.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	6o25-assembly3.cif.gz_I Crystal structure of 3945 Fab in complex with circumsporozoite protein NANP3 and anti-Kappa VHH domain	0.092	214	178	131	344	6	202	6.864E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6p95-assembly1.cif.gz_F	LOKIASV2_0429_ESMFold_hypothetical_protein	6p95-assembly1.cif.gz_F Structure of Lassa virus glycoprotein in complex with Fab 25.6A	0.074	227	194	129	355	4	213	4.207E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	5vpg-assembly1.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	5vpg-assembly1.cif.gz_D CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1	0.103	221	173	136	356	17	210	7.653E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6xul-assembly5.cif.gz_J	LOKIASV2_0429_ESMFold_hypothetical_protein	6xul-assembly5.cif.gz_J Apo Ab 5b1	0.080	230	191	129	358	4	212	5.229E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6acz-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6acz-assembly1.cif.gz_A The structure of CVA10 virus A-particle from its complex with Fab 2G8	0.081	327	199	87	413	1	217	9.514E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	8f5i-assembly1.cif.gz_X	LOKIASV2_0429_ESMFold_hypothetical_protein	8f5i-assembly1.cif.gz_X SARS-CoV-2 S2 helix epitope scaffold bound by antibody DH1057.1	0.090	216	181	129	344	4	203	6.156E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7neh-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7neh-assembly1.cif.gz_H Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 Fab	0.088	214	177	131	344	6	200	5.522E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7s8h-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7s8h-assembly1.cif.gz_H Structure of Lassa virus glycoprotein bound to Fab 18.5C and Fab 36.1F	0.094	226	186	131	356	7	212	6.501E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7chp-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7chp-assembly1.cif.gz_H Crystal structure of SARS-CoV-2 antibody P5A-3C8 with RBD	0.080	216	181	129	344	4	201	8.081E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6bf4-assembly2.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6bf4-assembly2.cif.gz_H Crystal Structure of HIV-1 Clade AE Strain CNE55 gp120 Core in Complex with Neutralizing Antibody VRC-PG05 that Targets the Center of the Silent Face on the Outer Domain of gp120	0.074	209	174	136	344	17	205	5.522E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	8bsf-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	8bsf-assembly1.cif.gz_H CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD-beta variant) in complex with 3D2 Fab	0.094	227	183	132	358	13	215	5.229E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6d11-assembly2.cif.gz_C	LOKIASV2_0429_ESMFold_hypothetical_protein	6d11-assembly2.cif.gz_C Crystal structure of 1450 Fab in complex with circumsporozoite protein NANP5	0.095	223	180	136	358	17	216	4.952E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7dm1-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	7dm1-assembly2.cif.gz_D crystal structure of the M.tuberculosis phosphate ABC transport receptor PstS-1 in complex with Fab p4-36	0.064	221	185	136	356	17	215	5.830E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7kkh-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	7kkh-assembly1.cif.gz_B P1A4 Fab in complex with ARS1620	0.096	216	179	129	344	4	202	6.156E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6m3c-assembly3.cif.gz_K	LOKIASV2_0429_ESMFold_hypothetical_protein	6m3c-assembly3.cif.gz_K hAPC-h1573 Fab complex	0.081	228	189	129	356	6	212	6.864E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6u8k-assembly3.cif.gz_F	LOKIASV2_0429_ESMFold_hypothetical_protein	6u8k-assembly3.cif.gz_F Crystal structure of hepatitis C virus IRES junction IIIabc in complex with Fab HCV3	0.092	228	192	129	356	4	215	8.081E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	3vrl-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3vrl-assembly1.cif.gz_H Crystal structure of BMJ4 p24 capsid protein in complex with A10F9 Fab	0.094	226	189	131	356	6	215	8.533E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7bnv-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7bnv-assembly1.cif.gz_H Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-300	0.067	212	179	133	344	14	206	8.081E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7rdl-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	7rdl-assembly2.cif.gz_D Crystal structure of PCDN-22A, an anti-HIV antibody from the PCDN bnAb lineage	0.096	212	173	133	344	15	206	7.653E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7ox4-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7ox4-assembly1.cif.gz_A Mouse interleukin-9 in complex with Fab 35D8.	0.081	230	198	129	358	4	219	7.653E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6ous-assembly1.cif.gz_M	LOKIASV2_0429_ESMFold_hypothetical_protein	6ous-assembly1.cif.gz_M Structure of fusion glycoprotein from human respiratory syncytial virus	0.091	226	192	131	356	6	217	6.501E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7u8j-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7u8j-assembly1.cif.gz_H Crystal structure of chimeric hemagglutinin cH4/3 in complex with broad protective antibody 31.a.83	0.094	214	183	131	344	6	208	9.514E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	4nrz-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4nrz-assembly1.cif.gz_H Crystal Structure of HIV-1 Neutralizing Antibody m66.6	0.088	225	188	132	356	13	219	7.653E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	4ris-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4ris-assembly1.cif.gz_H Structural Analysis of the Unmutated Ancestor of the HIV-1 Envelope V2 Region Antibody CH58 Isolated From an RV144 HIV-1 Vaccine Efficacy Trial Vaccinee and Associated with Decreased Transmission Risk	0.069	228	201	129	356	4	220	6.501E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	3mme-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	3mme-assembly2.cif.gz_A Structure and functional dissection of PG16, an antibody with broad and potent neutralization of HIV-1	0.074	209	187	136	344	17	219	5.830E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	6ulc-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6ulc-assembly1.cif.gz_H Structure of full-length, fully glycosylated, non-modified HIV-1 gp160 bound to PG16 Fab at a nominal resolution of 4.6 Angstrom	0.077	212	191	133	344	14	221	7.653E+00	9
LOKIASV2_0429_ESMFold_hypothetical_protein	7xsc-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7xsc-assembly1.cif.gz_A Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P5S-2B10	0.075	216	174	129	344	3	191	7.653E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	4xxd-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	4xxd-assembly1.cif.gz_B Crystal Structure of mid-region amyloid beta capture by solanezumab	0.077	228	182	129	356	3	200	9.010E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	6kvf-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6kvf-assembly2.cif.gz_A Structure of anti-hCXCR2 abN48 in complex with its CXCR2 epitope	0.079	216	176	129	344	2	193	9.514E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	8g2o-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	8g2o-assembly1.cif.gz_H Fab structure - Anti-ApoE-7C11 antibody	0.056	221	179	136	356	17	207	8.081E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	5x8l-assembly2.cif.gz_G	LOKIASV2_0429_ESMFold_hypothetical_protein	5x8l-assembly2.cif.gz_G PD-L1 in complex with atezolizumab	0.064	216	179	129	344	4	195	6.501E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	8dfi-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	8dfi-assembly1.cif.gz_H Crystal structure of moderately neutralizing / interfering human monoclonal antibody 42C11 Fab in complex with MSP1-19	0.098	223	171	136	358	17	207	7.653E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	7kgu-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	7kgu-assembly2.cif.gz_D Structure of 2Q1-Fab, an antibody selective for IDH2R140Q-HLA-B*07:02	0.086	228	186	129	356	3	206	9.010E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	7s7i-assembly4.cif.gz_U	LOKIASV2_0429_ESMFold_hypothetical_protein	7s7i-assembly4.cif.gz_U Crystal structure of Fab in complex with MICA alpha3 domain	0.090	221	172	136	356	17	206	8.533E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	6pyc-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	6pyc-assembly1.cif.gz_A Structure of kappa-on-heavy (KoH) antibody Fab bound to the cardiac hormone marinobufagenin	0.083	228	185	129	356	4	206	8.533E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	6pzf-assembly1.cif.gz_F	LOKIASV2_0429_ESMFold_hypothetical_protein	6pzf-assembly1.cif.gz_F Crystal structure of human NA-63 Fab in complex with neuraminidase from A/Hunan/02650/2016(H7N9)	0.098	221	170	136	356	17	206	6.501E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	7sx6-assembly2.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	7sx6-assembly2.cif.gz_B Crystal structure of broadly neutralizing antibody N49P9.3 Fab in complex with HIV-1 Clade A/E strain 93TH057 gp120 core	0.068	226	187	131	356	6	207	8.533E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	6ug8-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6ug8-assembly1.cif.gz_H Complex of ch28/11 Fab and SSEA-4 (monoclinic form)	0.083	223	175	136	358	17	208	8.081E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	4hs6-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	4hs6-assembly1.cif.gz_B Hepatitus C envelope glycoprotein E2 fragment 412-423 with humanized and affinity-matured antibody MRCT10.v362	0.094	209	161	136	344	17	195	9.514E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	7mzf-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7mzf-assembly1.cif.gz_H SARS-CoV-2 receptor binding domain bound to Fab PDI 37	0.076	228	187	129	356	4	206	9.010E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	8eb2-assembly1.cif.gz_K	LOKIASV2_0429_ESMFold_hypothetical_protein	8eb2-assembly1.cif.gz_K Structure of HLA-A*02:01 in complex with NY-ESO-1 peptide and PA2.1 Fab	0.057	216	183	129	344	4	198	8.081E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	8g1b-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	8g1b-assembly1.cif.gz_A Crystal structure of polyreactive 2G02 human Fab	0.083	212	168	133	344	16	199	9.010E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	3ifn-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	3ifn-assembly1.cif.gz_H X-ray structure of amyloid beta peptide:antibody (Abeta1-40:12A11) complex	0.079	228	186	129	356	4	206	6.864E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	6o25-assembly2.cif.gz_E	LOKIASV2_0429_ESMFold_hypothetical_protein	6o25-assembly2.cif.gz_E Crystal structure of 3945 Fab in complex with circumsporozoite protein NANP3 and anti-Kappa VHH domain	0.081	214	178	131	344	6	200	9.514E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	7quh-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7quh-assembly1.cif.gz_H Siglec-8 in complex with therapeutic Fab AK002.	0.075	227	189	131	357	6	210	8.081E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	8t9z-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	8t9z-assembly1.cif.gz_H Structural of M8C10 Fab in complex human metapneumovirus fusion protein	0.086	209	167	136	344	16	199	9.514E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	5wi9-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5wi9-assembly1.cif.gz_H Crystal structure of KL with an agonist Fab	0.053	214	185	131	344	5	200	9.514E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	4xgz-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	4xgz-assembly1.cif.gz_A Crystal structure of human paxillin LD2 motif in complex with Fab fragment	0.075	216	179	129	344	5	198	7.653E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	6xq2-assembly2.cif.gz_F	LOKIASV2_0429_ESMFold_hypothetical_protein	6xq2-assembly2.cif.gz_F Human antibody S8V2-37 in complex with the influenza hemagglutinin head domain of A/Texas/50/2012(H3N2)	0.097	207	166	138	344	17	201	9.514E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	4zyk-assembly2.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	4zyk-assembly2.cif.gz_A Crystal Structure of Quaternary-Specific RSV-Neutralizing Human Antibody AM14	0.086	214	179	131	344	5	201	8.533E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	4hk3-assembly1.cif.gz_J	LOKIASV2_0429_ESMFold_hypothetical_protein	4hk3-assembly1.cif.gz_J I2 Fab (unbound) from CH65-CH67 Lineage	0.078	228	191	129	356	4	211	9.514E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	7s8h-assembly1.cif.gz_B	LOKIASV2_0429_ESMFold_hypothetical_protein	7s8h-assembly1.cif.gz_B Structure of Lassa virus glycoprotein bound to Fab 18.5C and Fab 36.1F	0.072	212	172	133	344	16	201	9.010E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	7che-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7che-assembly1.cif.gz_A Crystal structure of the SARS-CoV-2 RBD in complex with BD-236 Fab and BD-368-2 Fab	0.087	215	178	142	356	16	211	6.501E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	4f58-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4f58-assembly1.cif.gz_H Fab structure of a neutralizing antibody L3 from an early subtype A HIV-1 infected patient	0.097	216	179	129	344	4	202	7.248E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	6mto-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6mto-assembly1.cif.gz_H Crystal structure of VRC42.01 Fab in complex with T117-F MPER scaffold	0.084	226	181	133	358	16	214	6.864E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	7o2z-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	7o2z-assembly1.cif.gz_H Crystal structure of the anti-PAS Fab 2.2 in complex with its epitope peptide	0.088	228	188	129	356	4	210	6.864E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	7msq-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	7msq-assembly2.cif.gz_D Complex between the Fab arm of AB-3467 and the SARS-CoV-2 receptor binding domain (RBD)	0.085	222	181	136	357	17	215	9.514E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	1ncb-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	1ncb-assembly1.cif.gz_H CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE	0.085	226	184	132	357	13	214	9.514E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	6o3u-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6o3u-assembly1.cif.gz_H Crystal structure of the Fab fragment of the human HIV-1 neutralizing antibody PGZL1.H4K3 in complex with 06:0 PA	0.096	221	178	136	356	17	214	8.533E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	7rfc-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	7rfc-assembly1.cif.gz_A Crystal structure of broadly neutralizing antibody mAb1382 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain	0.069	212	174	133	344	16	203	9.514E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	6apd-assembly1.cif.gz_F	LOKIASV2_0429_ESMFold_hypothetical_protein	6apd-assembly1.cif.gz_F Crystal structure of RSV F bound by AM22 and the infant antibody ADI-19425	0.094	228	189	129	356	4	213	8.081E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	8szy-assembly2.cif.gz_I	LOKIASV2_0429_ESMFold_hypothetical_protein	8szy-assembly2.cif.gz_I Crystal Structure of Heterotrimeric Anti-TIGIT Fabs in complex with human TIGIT	0.075	222	186	136	357	17	218	5.830E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	5ty6-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	5ty6-assembly1.cif.gz_H Crystal structure of the broadly neutralizing Influenza A antibody VRC 315 13-1b02 Fab.	0.070	221	186	136	356	17	217	8.081E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	4fql-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	4fql-assembly1.cif.gz_H Influenza B HA Antibody (Fab) CR8033	0.087	228	194	129	356	4	216	8.081E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	4fqq-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	4fqq-assembly2.cif.gz_D Crystal Structure of Germline Antibody PGT121-GL Fab	0.107	223	182	136	358	17	221	7.653E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	6umg-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6umg-assembly1.cif.gz_H Crystal structure of erenumab Fab bound to the extracellular domain of CGRP receptor	0.076	214	188	131	344	6	209	9.514E+00	8
LOKIASV2_0429_ESMFold_hypothetical_protein	6ana-assembly1.cif.gz_H	LOKIASV2_0429_ESMFold_hypothetical_protein	6ana-assembly1.cif.gz_H LL2 Fab in complex with anti-Kappa VHH domain	0.079	219	171	138	356	16	202	8.533E+00	7
LOKIASV2_0429_ESMFold_hypothetical_protein	5icz-assembly2.cif.gz_D	LOKIASV2_0429_ESMFold_hypothetical_protein	5icz-assembly2.cif.gz_D Cetuximab Fab in complex with GQFDLSTRRLKG peptide	0.090	216	175	129	344	4	196	9.514E+00	7
LOKIASV2_0429_ESMFold_hypothetical_protein	8db4-assembly1.cif.gz_A	LOKIASV2_0429_ESMFold_hypothetical_protein	8db4-assembly1.cif.gz_A Crystal structure of the peanut allergen Ara h 2 bound by two neutralizing antibodies 22S1 and 13T1	0.075	216	184	129	344	4	203	9.514E+00	7
